皮膚科王修含醫師

王修含醫師演講紀錄：

地點：台北國際會議中心 (台北市信義區信義路五段1號)

會議名稱：AMWC Asia-TDAC 2025 臺灣皮膚科醫學會春季學術討論會

講題一：Basic Principles of Ultrasonographic Imaging

超音波影像基本原理

時間：2025.5.2 13:30-14:00

講題二： Optimizing return electrode placement in monopolar RF for safety and efficacy: A mathematical and physical approach

透過數學與物理方法優化單極電波射頻回極位置，以提升安全性與療效

時間：2025.5.3 09:00-10:00

講題三： The biomechanics of safety: A quantitative approach to vascular-free filler injections

以生物力學為基礎的安全注射：完全避免血管栓塞併發症治療的量化分析途徑

時間：2025.5.4 16:00-17:00

擔任座長

時間：2025.5.3 12:30-13:30

KOL Interview專訪

時間：2025.5.3 14:30-14:50

ASSIGNMENT(S)
Friday, May 02, 2025 - from 1:30 PM to 5:00 PM // Room: JOY LOUNGE LEVEL 4
Session: Hands-On Ultrasound Course For Injectables Workshop
Your Assignment: Lecture - Basic principles of ultrasonographic Imaging
Assignment duration: 20 minutes Estimated assignment time: 13:35

Saturday, May 03, 2025 - from 9:00 AM to 10:00 AM // Room: ELEGANCE LOUNGE LEVEL 4
Session: Energy-based Devices : Rethink the Basics and Untold Truth
You are CHAIR of the session with MIYATA Nariaki.
Your Assignment: Lecture - Optimizing return electrode placement in monopolar RF for safety and efficacy: A mathematical and physical approach
Assignment duration: 15 minutes Estimated assignment time: 09:15

Saturday, May 03, 2025 - from 12:30 PM to 1:30 PM // Room: ELEGANCE LOUNGE LEVEL 4
Session: Luncheon Symposium by DMT
You are CHAIR of the session.

Sunday, May 04, 2025 - from 4:00 PM to 5:00 PM // Room: ELEGANCE LOUNGE LEVEL 4
Session: Key Takeaways: Aesthetic Medicine Toolbox - Global Best Practices
Your Assignment: Lecture - The biomechanics of safety: A quantitative approach to vascular-free filler injections
Assignment duration: 5 minutes Estimated assignment time: 16:45

Invitation to Social Events
Speakers' Welcome Dinner: 1 PERSON
Saturday, May 03, 2025 - Diamond Tony's Italian Restaurant, 85th Floor at Taipei 101 Tower
from 6:30 PM to 9:00 PM.

Friday, May 02, 2025 - 1:30 PM to 5:00 PM - Room: Joy Lounge Level 4
Hands-On Ultrasound Course For Injectables Workshop
Moderators: YANG Jason Chih-Hsun
SESSION DETAILS:
1:30 PM - 1:35 PM: Lecture - Opening & Introduce the speakers Prof. Jason Chih-Hsun Yang
1:35 PM - 1:55 PM: Lecture - Basic principles of ultrasonographic Imaging (20 minutes) Dr Shiou-Han Wang
1:55 PM - 2:15 PM: Lecture - Ultrasound imaging for facial muscles and neurovascular structures Dr Ke-Vin Chang
2:15 PM - 2:30 PM: Lecture - Where and when to use ultrasonography in botulinum neurotoxin, fillers, and threading procedures?
-Korean perspective
Dr Kyu-Ho Yi
2:30 PM - 2:45 PM: Lecture - Why & How to use Ultrasound when treating medical aesthetics patients - Brazilian perspective Dr Danilo Teixeira
2:45 PM - 3:00 PM: Lecture - Enhancing safer and more comprehensive aesthetic outcomes through real-time imaging Dr Henry Yau-Li Huang
3:00 PM - 3:40 PM: Workshop - Hands-on supervision - Upper Face + Bubble stations (40 minutes) Dr Yao-Yu Chang, Dr Henry
Yau-Li Huang, Dr Tanongkiet
Tienthavorn, Dr Danilo Teixeira,
Prof. Jason Chih-Hsun Yang
3:40 PM - 4:20 PM: Workshop - Hands-on supervision - Mid Face + Bubble stations (40 minutes) Dr Yao-Yu Chang, Dr Henry
Yau-Li Huang, Dr Tanongkiet
Tienthavorn, Dr Danilo Teixeira,
Prof. Jason Chih-Hsun Yang
4:20 PM - 5:00 PM: Workshop - Hands-on supervision - Lower face + Bubble stations (40 minutes) Dr Yao-Yu Chang, Dr Henry
Yau-Li Huang, Dr Tanongkiet
Tienthavorn, Dr Danilo Teixeira,
Prof. Jason Chih-Hsun Yang

Saturday, May 03, 2025 - 9:00 AM to 10:00 AM - Room: Elegance Lounge Level 4
Energy-based Devices : Rethink the Basics and Untold Truth
You are CHAIR of the session with MIYATA Nariaki.
SESSION DETAILS:
9:00 AM - 9:15 AM: Lecture - Picosecond laser-induced optical breakdown: A novel approach for reversing photo-aging at the molecular
level
Dr Chang-Cheng Chang
9:15 AM - 9:30 AM: Lecture - Optimizing return electrode placement in monopolar RF for safety and efficacy: A mathematical
and physical approach (15 minutes)
Dr Shiou-Han Wang
9:30 AM - 9:45 AM: Lecture - Novel mono & bipolar capacitive coupling RF: We should rethink the basics Dr Nariaki Miyata
9:45 AM - 10:00 AM: Lecture - Photodynamic therapy on skin cancers, HPV infection and photo-aging rejuvenation: A field approach to
up-regulate immunity
Dr Chung-Hsing Chang

Saturday, May 03, 2025 - 12:30 PM to 1:30 PM - Room: Elegance Lounge Level 4
Luncheon Symposium by DMT
You are CHAIR of the session.
SESSION DETAILS:
12:30 PM - 12:50 PM: Workshop - From Treatment to Aesthetic: How PLADUO Therapy is Revolutionizing Skin Disease Care and Beauty Dr Che-Hao Hsu
12:50 PM - 1:10 PM: Workshop - Picoway 730nm: Precision Pigment Targeting in Dermatology Dr Kang-Ling Kuo
1:10 PM - 1:30 PM: Workshop - Beyond the Surface: Clinical Applications of Focus Dual Fractional RF Microneedle (FRM) for skin
rejuvenation
Dr Yung-Tsung Huang

Sunday, May 04, 2025 - 4:00 PM to 5:00 PM - Room: Elegance Lounge Level 4
Key Takeaways: Aesthetic Medicine Toolbox - Global Best Practices
Moderators: SHETTY Rashmi, LU Sophie Pei-Hsuan
SESSION DETAILS:
4:00 PM - 4:05 PM: Lecture - The art of periorbital rejuvenation: Key strategies for a refreshed look Mr Allen Yao-Lin Huang
4:05 PM - 4:10 PM: Lecture - Combination of Surgical and Non-surgical Approaches to Under-Eye Bags Mr Sophie Pei-Hsuan Lu
4:10 PM - 4:15 PM: Lecture - Subzygoma lift : A filler facial lifting with cheek augmentation technique Dr Rassapoom Sumaetheiwit
4:15 PM - 4:20 PM: Lecture - Lips and my tips Dr Rashmi Shetty
4:20 PM - 4:30 PM: Panel Discussion - Q&A Part 1
4:30 PM - 4:35 PM: Lecture - Mastering subcision: Small moves, big results Dr Minh Doan Phan
4:35 PM - 4:40 PM: Lecture - Skin-needling antagonists - What NOT to do Dr Andrew Christie-Schwarz
4:40 PM - 4:45 PM: Lecture - Tailored skin layer targeting for different scar types using needle-free jet injector Dr Ji Yeoun Shin
4:45 PM - 4:50 PM: Lecture - The biomechanics of safety: A quantitative approach to vascular-free filler injections (5 minutes) Dr Shiou-Han Wang
4:50 PM - 5:00 PM: Panel Discussion - Q&A Part 2

附錄：本次大會完整的Abstract

ABSTRACTS MAIN SESSIONS
BASHIR Afzaal
Sunday, May 04, 2025 - from 13:30 to 15:30 102 LEVEL 1
Session:
Scar Treatment Strategies: From Healing to Perfection (Co-session TSPS)
DERMOGENESIS WITH MESENCHYMAL STEM CELLS: A FABULOUS REMEDY FOR POST ACNE
DEPRESSED SPOTS
Post acne depressed spots are due to localized fat atrophy and disruption of dermis. Treatment is very hard because of many
reasons as difficulty is excision due to their small size and large number. Subcision followed by filling is not adequately
treating the deformity. Despite of multi modalities, outcome is not satisfactory. This study compared long-term effects of
conventional fat grafting and ex-vivo expanded Mesenchymal Stem Cells (MSCs) enriched lipofilling for the treatment of post
acne depressed spots.
After informed consent, 40 patients having post acne spots on face were recruited and after explanation of types of treatment,
placed in two groups depending upon their choice. In lipofilling only group (LF-G), micro fat was harvested and filled intra
dermally and sub dermally in the depressed post acne spots. In MSC enriched lipofilling group (MSC-LF), fat was harvested,
MSCs were isolated, cultured to enrich fat before lipofilling intradermally and sub dermally in depressed spots. Improvement
was noted after one year. Increase in dermal thickness was confirmed on histological sections of small punch biopsies.
Mean age of patients was 26.32(±3.34) and 72% patients were females. Cheeks-only were involved in 57% cases. In MSC-LF
group, improvement in dermal thickness was 1.2(±0.6)mm in comparison to LF-G group which was 0.5(±0.3)mm. Patient and
physician satisfaction was more in MSC-LF group.
MSC enrichment is having pronounced effect in addressing post acne depressed spots by filling as well as increasing dermal
thickness.
BLAUVELT Andrew
Sunday, May 04, 2025 - from 10:30 to 12:30 201ABC LEVEL 2
Session:
Atopic Dermatitis
IL-13 IN ATOPIC DERMATITIS: UNLOCKING MECHANISMS OF NEW BIOLOGIC THERAPIES
Atopic dermatitis (AD) is a chronic inflammatory skin condition characterized by immune dysregulation, with IL-13 being a key
cytokine involved in its pathogenesis. Elevated IL-13 levels are observed in both skin and blood of AD patients, correlating
with disease severity and chronicity across different age groups and ethnicities. Dupilumab, an earlier biologic treatment,
targets the interleukin (IL)-4 receptor alpha subunit, inhibiting both IL-4 and IL-13 signaling. More recent biologics, such as
tralokinumab and lebrikizumab, specifically target IL-13, offering a more focused approach to modulating this cytokine. These
IL-13 inhibitors have shown efficacy in reducing inflammation and improving skin barrier function. In summary, IL-13 plays a
significant role in AD, and biologics targeting IL-13, including tralokinumab and lebrikizumab, provide alternative treatment
options with the potential to improve disease outcomes.
BOONTAVEEYUWAT Einapak
Saturday, May 03, 2025 - from 10:30 to 12:30 ELEGANCE LOUNGE LEVEL 4
Session:
Spotlight on Pigments: Mastering the Science and Cutting-edge Treatment (Co-session with DST)
BEYOND SUNSCREEN: LAYERING PROTECTION AGAINST KEY SKIN EXPOSOME FACTORS
Pigmentation concerns, including melasma and post-inflammatory hyperpigmentation are amongst the most prevalent
dermatological challenges in Asia. Emerging research highlights the critical role of the skin exposome—including ultraviolet
(UV) radiation, pollution, infrared radiation, blue light, and oxidative stress—in the onset and exacerbation of
hyperpigmentation. While broad-spectrum sunscreens are essential in pigment management, evidence suggests that a
multi-layered defence strategy—combining advanced UV filters with antioxidants, DNA repair enzymes, and
pigment-regulating agents—can provide superior protection and correction.
This presentation will examine the interplay between environmental aggressors and melanogenesis, emphasising the role of
potent antioxidants, ultra broad-spectrum filters and iron oxide-based formulations for blue light protection, and emerging
skincare technologies in mitigating pigmentary disorders. Additionally, we will explore the latest clinical data on combining
photoprotection with depigmenting agents, optimising skincare protocols for patients prone to hyperpigmentation.
CELIK Naci
Saturday, May 03, 2025 - from 16:00 to 18:00 102 LEVEL 1
Session:
Non-surgical Lifting / Thread Lifts: The Art and Science Behind (co-session with MIPS)
DEEP PLANE THREAD LIFTING
The use of non-absorbable silicone threads for facial suspension has emerged as an innovative approach in facial
rejuvenation and contouring. Unlike traditional thread suspension systems, this technique focuses on anchoring the deeper
plane tissues, specifically the superficial musculoaponeurotic system (SMAS). The threads are strategically placed either
under or within the SMAS layer, providing a more stable and durable lifting effect. This approach addresses common
challenges in thread lifting, such as limited longevity and inadequate support for deeper facial tissues, by creating a robust
foundation for repositioning and sustaining soft tissues.
This technique can also be effectively combined with open face-lift procedures, enhancing surgical precision and efficiency.
When used in conjunction with face-lift surgery, silicone threads facilitate smoother operations by providing pre-anchorage
and creating better tension management in the SMAS layer, ultimately leading to improved aesthetic outcomes. The
non-absorbable nature of silicone threads ensures prolonged support and minimizes the need for frequent follow-up
procedures.
Preliminary clinical experiences suggest that this method is particularly beneficial for patients seeking longer-lasting results
and enhanced facial contouring, with minimal added complexity for surgeons. Further studies are required to evaluate
long-term outcomes, patient satisfaction, and complication rates compared to other thread suspension systems. This
innovative application offers promising potential in the field of facial rejuvenation.
CELIK Naci
Saturday, May 03, 2025 - from 17:00 to 18:00 JOY LOUNGE LEVEL 4
Session:
Optimized Rejuvenation: Expert Combination Strategies
OFFICE BASED REGENERATIVE MEDICINE WITH THE COMBINATION OF THREAD, FAT, LASER AND
EXOSOME
Office-based regenerative medicine has become a cornerstone in modern aesthetic and anti-aging treatments, offering
minimally invasive solutions with maximum impact. This presentation explores the synergistic combination of advanced
techniques, including thread face suspension systems (absorbable and non-absorbable), fat injection, laser treatments, and
exosome applications, to achieve comprehensive facial rejuvenation and contouring. The integration of these methods
enables both structural support and cellular regeneration, delivering natural, long-lasting results.
Thread suspension systems provide mechanical lifting and repositioning of facial tissues. Absorbable threads stimulate
collagen production, enhancing skin texture and elasticity, while non-absorbable threads offer deeper tissue anchorage and
prolonged structural support, particularly in challenging cases. Fat injection techniques, leveraging autologous adipose tissue
as a volumetric filler, are enhanced by the regenerative properties of adipose-derived stem cells, promoting vascularization
and tissue integration.
Laser treatments further complement the regenerative process by improving skin tone, texture, and pigmentation through
controlled dermal remodeling. Exosomes, as nanosized extracellular vesicles derived from stem cells, amplify the rejuvenation
process by modulating inflammatory responses, promoting angiogenesis, and stimulating cellular repair and regeneration.
The combination of these techniques offers a multidimensional approach to facial rejuvenation, addressing not only sagging
and volume loss but also skin quality and cellular health. This approach is particularly effective for patients seeking natural
results with minimal downtime. The presentation will also feature a detailed surgical video demonstrating the integration of
these techniques, providing attendees with practical insights into patient selection, procedural workflows, and postoperative
care.
This comprehensive strategy underscores the potential of regenerative medicine to redefine office-based aesthetic
treatments. By combining innovative technologies and techniques, practitioners can deliver personalized, high-impact results,
aligning with the growing demand for minimally invasive, regenerative approaches in aesthetic medicine.

CHANG Chang-Cheng
Saturday, May 03, 2025 - from 09:00 to 10:00 ELEGANCE LOUNGE LEVEL 4
Session:
Energy-based Devices : Rethink the Basics and Untold Truth
PICOSECOND LASER-INDUCED OPTICAL BREAKDOWN: A NOVEL APPROACH FOR REVERSING
PHOTO-AGING AT THE MOLECULAR LEVEL
Background: Photoaging, driven by prolonged ultraviolet (UV) exposure, significantly
impacts skin aesthetics and health. Traditional treatments vary in efficacy and
invasiveness. This study evaluates the effectiveness of 755 nm picosecond laser-
induced optical breakdown (LIOB) combined with a diffractive lens array as a novel,
minimally invasive treatment for photoaging.
Methods: A controlled study was conducted on female BALB/cAnN.Cg-
Foxn1nu/CrlNarl mice exposed to UVA and UVB radiation to induce photoaging. Mice
were treated with the PICOSURE® 755 nm picosecond laser. Changes in wrinkle
formation, skin elasticity, collagen degradation, and skin barrier function were
assessed. Key proteins analyzed included Smad 2/3, p-p38, and MMP-9.
Results: Laser treatment significantly improved skin texture, reducing wrinkle formation
and erythema. Collagen intensity increased significantly post-treatment, with marked
reductions in MMP-9 expression (47.3% decrease, p
Smad 2/3 (68.2% increase, p
Histological staining confirmed enhanced collagen content (10.3% increase in UVA-
L(+) and 23.6% in UVB-L(+) groups, p
Conclusions: The 755 nm picosecond laser-induced optical breakdown offers a
promising, minimally invasive approach to treating photoaging. By targeting molecular
mechanisms underlying UV-induced skin damage, this treatment enhances skin
regeneration, collagen production, and barrier function restoration. These findings
suggest this laser therapy may surpass traditional treatments in efficacy, with minimal
adverse effects, marking a significant advancement in dermatological care for photoaging.
CHANG Cheng-Hsien
Saturday, May 03, 2025 - from 13:30 to 15:30 NORTH LOUNGE (ACDS) LEVEL
3
Session:
Dermatologic Aesthetic Surgery: Comprehensive and Concise Methods for Improving Your Results
(co-session TAFPRS/TSOPRS)
MANAGEMENT OF BLEPHAROPTOSIS
Eyelid ptosis is not only a cosmetic concern but also a visual disturbance. To elevate the eyelids, the protection of cornea has
to be considered. Significant lagophthalmos has be avoided in pursuit of a "big eye". Therefore, preoperative evaluation is
mandatory, including margin reflex distance (MRD), levator muscle function, Bell's phenomenon, tear film stability and tear
production (e.g. Schirmer test). Levator advancement or resection is only reserved for patients with small MRD. Those with
redundant upper eyelid skin such as dermatochalasis usually do not need manipulation of levator muscle. Patients with brow
ptosis can be suggested to have a brow lift. An incision close to the brow usually leaves a significant scar. However
endoscopic brow lift is technique and cost demanding. Patients with poor levator muscle function frequently end up with
severe lagophthalmos and cornea epithelial defects pain or ulcer in an aggressive resection of levator muscles, which is
strongly not suggested. In conclusion, a harmless ptosis surgery is the best policy in upper eyelid blepharoplasty.
CHANG Wei-Ting
Sunday, May 04, 2025 - from 13:30 to 15:30 ELEGANCE LOUNGE LEVEL 4
Session:
Body Aesthetics 2025: What's Cool about Body-Fat, Sweat and Smell
ADVANCED NON-INVASIVE BODY CONTOURING STRATEGIES FOR LOW TO NORMAL BMI PATIENTS: A
HOLISTIC APPROACH TO AESTHETIC ENHANCEMENT
As patient demand grows for aesthetic improvement without surgery, particularly in individuals with low to normal BMI, there is
increasing interest in advanced non-invasive body contouring technologies that go beyond fat reduction to include muscle
toning and skin tightening. This presentation explores a holistic approach to body sculpting through the integration of
cryolipolysis and electromagnetic muscle stimulation (EMMS), focusing on their combined efficacy, safety, and patient
satisfaction outcomes.
We will also discuss real-world clinical considerations. This holistic, non-invasive strategy presents a promising advancement
for enhancing aesthetic outcomes in patients not suited for traditional surgical intervention.
CHAUCHARD Claude
Saturday, May 03, 2025 - from 13:30 to 15:30 ELEGANCE LOUNGE LEVEL 4
Session:
Anti-aging in the Era of Aesthetics (Co-session with AMWC Japan)
INSULIN RESISTANCE IN AGING PROCESS. HOW TO CONTROL?
Insulin resistance is a condition in which the body's cells do not effectively respond to insulin, the hormone produced
by the pancreas that allows glucose (sugar) to enter the cells through what are known as sugar channels. This
condition is a major factor in the development of type 2 diabetes and pre-diabetes.
Pre-diabetes is defined as when blood sugar levels are between 1.05 g/L and 1.25 g/L, confirmed by repeated testing
one month apart. If blood sugar levels exceed 1.25 g/L, it indicates type 2 diabetes.
Controlling insulin resistance is crucial because it helps prevent the progression to high-risk conditions, particularly
cardiovascular diseases and inflammatory diseases caused by excess sugar in the blood. Therefore, managing insulin
resistance should be a priority in preventive medicine and aging management.
CHEN Yung-Yuan
Saturday, May 03, 2025 - from 13:30 to 15:30 NORTH LOUNGE (ACDS) LEVEL
3
Session:
Dermatologic Aesthetic Surgery: Comprehensive and Concise Methods for Improving Your Results
(co-session TAFPRS/TSOPRS)
DEVIATED NOSE CORRECTION: CENTERING A DEVIATED NOSE BY CAUDAL SEPTAL EXTENSION GRAFT
AND EXTENDED SPREADER GRAFTS
The deviated nose presents a tremendous challenge for rhinoplasty surgeons, especially the correction of the cartilaginous
dorsum deviation. In this study, we introduce the surgical techniques of correcting a deviated cartilaginous vault by creating a
new center of the lower third using a caudal septal extension graft combined with unilaterally extended spreader grafts.
Centering the cartilaginous vault using a caudal septal extension graft combined with unilaterally extended spreader grafts is a
useful technical option in the correction of a deviated nose, and provides improvement in nasal tip projection and nostril
shape.
CHEN Yi-Chin
Saturday, May 03, 2025 - from 10:30 to 12:30 NORTH LOUNGE (ACDS) LEVEL
3
Session:
How Would You Reconstruct? The Repair Techniques of Skin Defects Including Tumor Surgery or
Cosmetic Purpose
MY TECHNIQUE IN NAIL SURGERY: TIPS FROM THE EXPERT
Nails have special anatomic structures. It's common to cause nail deformity after the nail surgery if we do the surgery rudely.
In this presentation, I will share some tips to improve the nail surgery skills.
CHEN Wen-Wen
Saturday, May 03, 2025 - from 09:00 to 10:00 201ABC LEVEL 2
Session:
Drug Reaction (Drug Allergy Cancer Treatment-related Skin Reaction)
DRUG RELIEF SYSTEM AND EXPERIENCE IN TAIWAN
Taiwan's drug injury relief system, established in 1999, was designed to provide timely and compassionate compensation for
individuals who suffer unexpected and serious adverse drug reactions. Over the past 25 years, this no-fault mechanism has
not only fulfilled its humanitarian purpose but has also become a vital component of the nation's post-marketing drug safety
framework.
This presentation will explore the development, implementation, and achievements of Taiwan's drug injury relief system. It will
highlight relief cases involving skin reactions associated to cancer treatments, aiming to raise awareness of potential safety
concerns in oncology care. By identifying early risk signals, these insights demonstrate how the relief system is evolving into a
proactive mechanism for preventing drug-related harm.
CHEN Yang-Yi
Sunday, May 04, 2025 - from 11:30 to 12:30 101A LEVEL 1 (MANDARIN)
Session:
Recent Advances in Photodermatology
EXPLORING UV-RELATED SKIN CANCER IN SYSTEMIC DISEASES WITH SPECIAL FOCUS ON DIABETES
Skin cancer, notably induced by ultraviolet (UV) radiation, represents a significant concern among patients with various
systemic diseases, including organ transplant recipients, chronic kidney disease, and autoimmune conditions such as
rheumatoid arthritis and psoriasis, all of which have increased skin cancer risks. Interestingly, diabetes mellitus demonstrates
an unusual pattern in susceptibility to photocarcinogenesis. Although chronic hyperglycemia typically increases cancer risks in
solid organs, the association with non-melanoma skin cancer (NMSC) remains unclear, with conflicting findings and
unexpectedly lower incidences reported in some studies.
This presentation reviews current evidence on UV-related skin cancer risks associated with systemic diseases, emphasizing
diabetes and its unique effects on epidermal responses to UV radiation. We highlight recent key findings from our
investigation, revealing that elevated glucose concentrations significantly modulate human epidermal keratinocyte responses
to UVB radiation, potentially explaining diabetic skin's altered resistance to UV-induced carcinogenesis. These findings
deepen our understanding of diabetic skin biology and suggest novel pathways for developing targeted strategies to prevent
skin cancer.
CHEN Chien Ming
Saturday, May 03, 2025 - from 10:30 to 12:30 102 LEVEL 1
Session:
Injectables and Botulinum Toxins 101: From Basic to Practical
CONFESSIONS OF A FACIAL OVERFILLED SYNDROME VICTIM - HOW I MAKE THEM RETURN TO NATURE
A 40-year-old female came to our clinic and complained that she had received 1000 shots of Ultraformed 3 in other clinic to
improve her sagging, and the main treated areas over the middle, lower face and neck. However, on the third day, she began
to experience abnormal swelling, pain and discomfort over a large area of ??her face. During the consultation, it was found
that there was no obvious superficial redness but evident symmetrical swelling. The patient recalled that she had received
PDLLA injection 3 years before receiving the HIFU treatment. Ultrasound examination revealed that the previuos injection
sites such as temples, infraorbital hollws, lateral cheeks, NLF, etc. had very obvious large-scale hypo-echoic mass and tissue
edema reaction. After about 2 months of oral doxycycline and prednisolone treatment, the swelling was significantly improved,
but there was still visible and palpable localized bump in the aforementioned areas. After 2 months, I performed intralesional
triamcilone under ultrasound guidance and the condition finally returned to normal. I would also like to share my personal
treatment alogorism and experience for filler complications, hoping to give everyone a basic treatment idea when dealing with
filler complications.
CHEN Shujun
Saturday, May 03, 2025 - from 10:30 to 12:30 NORTH LOUNGE (ACDS) LEVEL
3
Session:
How Would You Reconstruct? The Repair Techniques of Skin Defects Including Tumor Surgery or
Cosmetic Purpose
CLINICAL CASE&NBSP;OF PHOTODYNAMIC THERAPY FOR VULVAR BOWEN'S DISEASE
Genital Bowen's disease is a kind of malignant skin tumor that occurs on mucosal areas. For many patients, the pain that may
arise during the surgical operation and the recovery process, as well as the severe impact on appearance, are the reasons for
their fear of surgery. Therefore, we treated genital Bowen's disease with photodynamic therapy and conducted follow-up
observations to examine the benefits and long-term effects brought about by this kind of method.
CHENG Carl Kuo-Liang
Sunday, May 04, 2025 - from 10:30 to 12:30 102 LEVEL 1
Session:
The Future is Now: Regenerative Medicine, Cell Therapies Microbiome (co-session TSSCR)
COMBINATIONS OF EXOSOME WITH SCAFFOLD IN FACIAL AGING - REMODELING OR REGENERATION IN
DIFFERENT INDICATIONS?
Here we present the either exosome alone or combinations of artificial and nature scaffold with exosome for different
indication. And we'll discuss the results in different indications of anti-aging.
CHIU Pin-Chi
Saturday, May 03, 2025 - from 10:30 to 12:30 201ABC LEVEL 2
Session:
Acne and Rosacea - Think Outside the Box
THE POTENTIAL ROLE OF JAK INHIBITOR IN ACNE ROSACEA TREATMENT
Acne and rosacea are common inflammatory diseases that primarily affects the facial area, with a complex pathogenesis and
a variety of treatment options. In recent years, with deeper research into the pathogenesis of acne and rosacea, it has been
discovered that the Janus Kinase-Signal Transducer and Activator of Transcription (JAK-STAT) signalling pathway may be
involved in the development of acute and severe inflammatory reactions in these diseases. And JAK inhibitors are expected to
become a new therapeutic approach for these conditions. In this talk, I will share my experiences about the roles of using JAK
inhibitors in the management of acne and rosacea.
CHO Yung-Tsu
Sunday, May 04, 2025 - from 16:00 to 17:00 201ABC LEVEL 2
Session:
Urticaria and Pruritus
USE OF JAK INHIBITORS IN THE MANAGEMENT OF URTICARIAL VASCULITIS AND URTICARIAL
VASCULITIS-LIKE SEVERE CHRONIC URTICARIA
Chronic urticaria is typically characterized by the presence of wheals that spontaneously resolve within 24 hours. However,
when wheals persist for an extended period, the diagnosis of urticarial vasculitis (UV) should be considered, and a skin biopsy
should be performed. A diagnosis of UV is confirmed if histological evidence of vasculitis is present. In cases where vasculitis
is not histologically evident or a biopsy is not conducted, the condition may be classified as UV-like severe chronic
spontaneous urticaria (CSU). The prolonged nature of lesions and high symptom burden associated with UV and UV-like CSU
can significantly impair the quality of life of affected patients. Despite this, a consensus on treatment remains lacking. These
patients often require systemic corticosteroids or other immunomodulatory therapies. In this presentation, I will share my
experience with the use of Janus kinase (JAK) inhibitors in treating these conditions.
CHOI Jiwoong
Saturday, May 03, 2025 - from 13:30 to 15:30 NORTH LOUNGE (ACDS) LEVEL
3
Session:
Dermatologic Aesthetic Surgery: Comprehensive and Concise Methods for Improving Your Results
(co-session TAFPRS/TSOPRS)
OUTPATIENT NAIL SURGERY PROCEDURES: A GUIDE WITH VIDEO DEMONSTRATIONS
The nail unit is a crucial component of one of the body's most functionally significant structures—the fingertip—playing a vital
role in protecting the fingers and toes from external environmental factors while enhancing dexterity and precision in grasping
objects. It comprises three distinct epithelial structures: the nail matrix, nail bed, and paronychium, each of which can be
affected by various pathological conditions. Due to continuous exposure to physical trauma and other external stimuli, nail
disorders can present with a wide range of clinical manifestations. While most nail conditions can be managed with
conservative treatments or topical medications, surgical intervention is necessary in cases requiring biopsy, treatment of
severe ingrown nails, or excision of tumors.
This lecture will provide dermatologists with a comprehensive overview of essential knowledge, including the anatomical
structure of the nail unit, key surgical instruments, local anesthesia techniques, fundamental surgical procedures, and the
surgical management of benign tumors that can be performed in an outpatient clinic. Additionally, I will share a series of
surgical videos demonstrating procedures I have performed. This video-assisted lecture aims to enhance your understanding
of nail surgery techniques and their clinical applications.
CHU Chia-Bao
Sunday, May 04, 2025 - from 13:30 to 15:30 101A LEVEL 1 (MANDARIN)
Session:
From Bench to Bedside (by TSID)
HIDRADENITIS SUPPURATIVA: BRIDGING BASIC RESEARCH AND CLINICAL APPLICATION
Hidradenitis suppurativa (HS) is a chronic, recurrent inflammatory skin disorder with profound psychosocial impact. Despite
advances in understanding its complex pathogenesis, delayed diagnosis remains a global challenge—particularly in Asia,
where male predominance is observed. Our research combines bioinformatics, transcriptomics, immunohistochemistry, and
single-cell RNA sequencing to identify key pathogenic mediators. Clinical investigations further highlight regional and
sex-based disparities in disease presentation, influenced by factors such as smoking and hormonal regulation. By integrating
molecular findings with clinical observations, our work elucidates novel diagnostic markers and therapeutic targets, advancing
toward precision medicine for HS.
GKOUVI Aikaterini
Saturday, May 03, 2025 - from 11:30 to 12:30 JOY LOUNGE LEVEL 4
Session:
The Global Perspective: Gender, Culture Modern Aesthetic Practice
HETEROLOGOUS TYPE I COLLAGEN FOR VULVAR LICHEN SCLEROSUS AND GENITAL REJUVENATION:
A NOVEL THERAPEUTIC APPROACH
Title: "Heterologous Type I Collagen for Vulvar Lichen Sclerosus and Genital Rejuvenation: A Novel Therapeutic Approach"
Introduction & Objectives:
Collagen, particularly Type I collagen, is a key structural protein in the skin, essential for tissue regeneration and repair.
Injectable collagen has been extensively utilized in anti-aging treatments due to its ability to enhance dermal structure,
promote skin elasticity, and stimulate collagen production. In this presentation, the mechanism of action of Heterologous Type
I Collagen (HTIC) will be explained, showcasing its transition from anti-aging applications to therapeutic uses in dermatology.
We explore the efficacy and safety of HTIC in treating Vulvar Lichen Sclerosus (VLS), a chronic inflammatory dermatosis that
significantly affects patients' quality of life and poses challenges due to the limitations of current treatments. Additionally, we
will discuss its potential role in genital rejuvenation.
Materials & Methods:
HTIC, in a dose of 100 mg dissolved in 4.5 ml of normal saline and 0.5 ml of lidocaine, was administered through intradermal
or subdermal injections in a grid pattern at 1 cm intervals to the affected areas. Patients received four treatments at two-week
intervals. The presentation will also include an evaluation of HTIC's effects on skin texture, elasticity, and patient satisfaction
in the context of genital rejuvenation.
Results:
Patients showed significant improvement in VLS symptoms, with a reduction in lesion size observed after the first treatment
and complete resolution by the third. Symptoms such as pruritus, soreness, and dyspareunia were notably relieved.
Additionally, patients reported enhanced skin texture and elasticity in the genital area, contributing to improved satisfaction
and well-being. No relapses occurred over a 12-month follow-up period, with only minimal maintenance required.
Conclusion:
HTIC emerges as a promising treatment for Vulvar Lichen Sclerosus, providing both therapeutic relief and aesthetic benefits
through genital rejuvenation. The positive outcomes support further research into HTIC as a valuable addition to treatment
options for VLS and beyond. The presentation will address these findings, along with the underlying mechanisms and broader
implications for regenerative medicine.
GKOUVI Aikaterini
Sunday, May 04, 2025 - from 10:30 to 12:30 102 LEVEL 1
Session:
The Future is Now: Regenerative Medicine, Cell Therapies Microbiome (co-session TSSCR)
HETEROLOGOUS TYPE I COLLAGEN: THE REVOLUTIONARY INNOVATION FOR SKIN REGENERATION
Title: "Heterologous Type I Collagen: Revolutionizing Dermal Biostimulation"
Abstract:
Introduction: Mesotherapy with non-cross-linked hyaluronic acid (HA) has long been a cornerstone in skin hydration
treatments, often enhanced by combining HA with biorevitalization cocktails containing vitamins, minerals, amino acids,
nucleotides, coenzymes, and antioxidants. A major advancement in the field of skin regeneration is the use of Type I soluble
collagen, which acts as a natural scaffold, promoting the adhesion, growth, and differentiation of connective tissue cells. Since
its emergence in 2015, Heterologous Type I Collagen (HTIC) has revolutionized dermal regeneration by significantly
enhancing fibroblast proliferation and collagen production. HTIC has been widely adopted in Cosmetic Medicine and
Anti-Aging Therapies, providing an optimal environment for restoring connective tissues and supporting physiological collagen
synthesis. For nearly three decades, lyophilized HTIC patches have been effectively used in Dermatology, Angiology, and
Vascular Surgery for treating skin ulcers, open wounds, scars, and bedsores. This study introduces HTIC, detailing its
mechanisms of action, therapeutic indications, and its safety and efficacy profiles.
Objective: This study aims to evaluate the biostimulatory effects of HTIC across various body regions, including the face,
neck, décolleté, hands, lips, periorbital area, arms, abdomen, and thighs/buttocks. Additionally, the study examines
patient-reported discomfort and potential side effects associated with the treatment.
Materials and Methods: A cohort of 423 women, with a median age of 42 years and exhibiting signs of cutaneous aging,
participated in this study. Each subject received intradermal injections of HTIC, with treatment areas including the face, neck,
décolleté, hands, lips, periorbital area (around the eyes), arms, abdomen, and thighs/buttocks. The treatment protocol
consisted of four sessions administered at two-week intervals. Outcomes were documented through pre- and post-treatment
photography, alongside clinical evaluations following each session. Pain levels during the injections were also recorded by
patients.
Results: Nearly all treated patients exhibited significant improvements in skin quality following HTIC therapy, including
enhanced elasticity and firmness in all treated areas. Patient-reported discomfort was minimal to moderate, with no adverse
side effects observed.
Conclusion: HTIC represents a state-of-the-art biostimulation treatment, offering sustained improvements in skin quality,
including enhanced elasticity and firmness across multiple body areas, including the face, neck, hands, lips, and periorbital
region. The treatment demonstrates a high level of efficacy and safety. Ongoing extensive clinical trials are underway to
further validate these findings. HTIC holds transformative potential for the future of dermal biostimulation therapies.
GKOUVI Aikaterini
Sunday, May 04, 2025 - from 13:30 to 15:30 102 LEVEL 1
Session:
Scar Treatment Strategies: From Healing to Perfection (Co-session TSPS)
HETEROLOGOUS TYPE I COLLAGEN: EXPANDING APPLICATIONS FROM ANTI-AGING TO DERMAL
REGENERATION-HEALING-STIMULATION
Title: "Heterologous Type I Collagen: Expanding Applications from Anti-Aging to Dermal Regeneration-Healing-Stimulation "
Abstract:
Collagen is a critical component in tissue regeneration, serving as a natural substrate for the adhesion, growth, and
differentiation of connective tissue cells. Type I soluble collagen, widely recognized for its regenerative properties, has been a
cornerstone in Cosmetic Medicine and Anti-Aging Treatments since 2015. Heterologous Type I Collagen (HTIC) enhances
dermal biorevitalization by creating optimal conditions for the restoration of connective tissue and the physiological
neoformation of collagen.
Originally developed for anti-aging applications, HTIC has shown significant promise beyond its initial purpose, with potential
therapeutic benefits in treating a variety of dermatological conditions. This presentation aims to evaluate the efficacy of HTIC
not only as an anti-aging treatment but also as a dermal regenerator for conditions such as steroid-induced cutaneous
atrophy, atrophic acne scars, non-segmental vitiligo, plaque psoriasis, alopecia areata and androgenic alopecia. The
mechanism of action of HTIC and its anti-aging protocol will also be discussed.
Materials and Methods:
The study involved patients diagnosed with steroid-induced cutaneous atrophy, atrophic acne scars, non-segmental vitiligo,
plaque psoriasis, and alopecia areata. Each patient underwent four HTIC intradermal injection treatments, administered
biweekly. Photographic documentation was collected before and after each session, and clinical evaluations were conducted
to assess changes in skin condition. Patient-reported pain levels during the injection process were also recorded.
Results:
In the majority of cases, areas treated with HTIC showed significant improvement in skin quality, with many patients
experiencing complete resolution of their lesions. Reported pain during the injections was minimal to moderate, and no
adverse side effects were observed.
Conclusion:
HTIC proves to be an effective and safe dermal regenerator, offering substantial benefits not only in anti-aging but also in the
treatment of various dermatological conditions. Ongoing clinical trials aim to further validate HTIC as a comprehensive
treatment option, potentially revolutionizing the approach to conditions lacking definitive cures or universally effective
therapies

provide a morphology-based approach to scar revision, they often overlook broader aesthetic and structural concerns critical
to achieving optimal outcomes.
The CDIS approach is proposed as a novel and comprehensive framework for acne scar revision, addressing Contour, Dents
(or Divots), Icepick scars and Skin quality as an innovative and holistic methodology.
Through illustrative case studies, the CDIS approach integrates scar-specific treatments with strategies to restore facial
contours and enhance skin quality, offering a holistic solution for acne scar revision. Contour correction restores facial
harmony using soft tissue injectables like hyaluronic acid and calcium hydroxyapatite, while dents/divots are treated with
subcision, energy-based devices and injectables to release tethered scars and stimulate collagen remodeling. Icepick scars
are managed with CROSS using TCA or phenol peels, surgical excision and laser resurfacing. Skin quality enhancement
involves interventions targeting dyschromia, vascular normalisation, hydration and sebum regulation, utilising topicals,
energy-based devices and injectables.
By combining scar-specific therapies with enhancements to skin quality and facial structure, the CDIS approach provides a
practical, patient-centred tool for clinicians and ensures superior outcomes for acne scar patients.
HSIEH Paul-Chen
Sunday, May 04, 2025 - from 10:30 to 12:30 201ABC LEVEL 2
Session:
Atopic Dermatitis
COMPARISON OF BIOLOGICS IN ATOPIC DERMATITIS TREATMENT
The introduction of biologics, exemplified by dupilumab, has dramatically changed how we view and manage atopic
dermatitis. What should we know about the other available biologics for atopic dermatitis? How do they differ and how should
we decide on the optimal choice? We will discuss these questions in this session.
HSU Che-Hao
Sunday, May 04, 2025 - from 10:30 to 12:30 ELEGANCE LOUNGE LEVEL 4
Session:
Energy-based Devices : Exploring the New Frontier
REVOLUTIONIZING SKINCARE: THE ROLE OF PLASMA DEVICES IN DERMATOLOGY AND AESTHETIC
MEDICINE
In recent years, plasma-based technology has emerged as a groundbreaking innovation in both dermatology and aesthetic
medicine. Plasma devices, particularly those utilizing cold atmospheric plasma (CAP), have demonstrated significant
therapeutic and cosmetic potential due to their ability to generate reactive oxygen and nitrogen species (RONS) that interact
with the skin at the molecular, cellular, and tissue levels. Clinically, plasma treatments have shown promising outcomes in
managing a range of dermatologic conditions, including acne, wounds, infections, and inflammatory skin diseases.
Simultaneously, CAP is gaining popularity in aesthetic procedures for its ability to stimulate collagen remodeling, enhance skin
permeability, and promote rejuvenation—all while remaining minimally invasive and well-tolerated. This presentation will
explore the mechanisms of action, clinical evidence, safety profiles, and future outlook of plasma devices, highlighting their
dual role in advancing both therapeutic dermatology and aesthetic enhancement. By bridging science and beauty, plasma
technology is redefining the standards of modern skincare.
HUANG Henry Yau-Li
Saturday, May 03, 2025 - from 16:00 to 18:00 NORTH LOUNGE (ACDS) LEVEL
3
Session:
New Horizons in Dermatologic and Aesthetic Surgery
ENHANCING SAFER AND MORE COMPREHENSIVE AESTHETIC OUTCOMES THROUGH REAL TIME
IMAGING
Triple real-time imaging with vein detector (transillumination) and ultrasound plus Doppler can bridge the chasm between
facial surface anatomy and cadaveric or surgical anatomy. Despite being familiar with facial clinical anatomy and safety
measures of fillers injection or other aesthetic therapeutic modalities, we still never know the real facial anatomical variations
of the patient just in front of us. Thus, I am going to introduce the role of transillumination, ultrasound and Doppler in the field
of comprehensive aesthetic therapy, and to elaborate how to make our daily aesthetic practice safely and precisely with them.

HUANG Shu Hung
Sunday, May 04, 2025 - from 13:30 to 15:30 102 LEVEL 1
Session:
Scar Treatment Strategies: From Healing to Perfection (Co-session TSPS)
NEW FRONTIERS IN SCAR THERAPY: TRANSFORMATIVE APPROACHES IN SCAR REDUCTION
Effective scar management requires a proactive and individualized approach based on risk stratification and evidence-based
therapies. This presentation reviews the pathophysiology and classification of hypertrophic scars and keloids, and outlines
contemporary prevention and treatment modalities, including silicone gel sheeting, botulinum toxin injection, corticosteroid
therapy, pressure therapy, surgical excision with adjuvant radiotherapy, laser treatments, cryotherapy, and emerging
techniques such as microneedle drug delivery and artificial dermis application. Clinical protocols and case experiences from
Kaohsiung Medical University Hospital demonstrate the effectiveness of early intervention. A multi-modal strategy combining
mechanical, pharmacological, and biological interventions is recommended to optimize scar outcomes.
HUANG Hui-Peng
Saturday, May 03, 2025 - from 10:30 to 12:30 201ABC LEVEL 2
Session:
Acne and Rosacea - Think Outside the Box
MY HOLISTIC APPROACH TO MANAGEMENT OF ROSACEA
Rosacea is a multifactorial chronic inflammation of the facial skin. The pathophysiology involves two main changes:
neurovascular abnormalities and inflammatory processes. The neurovascular abnormalities include telangiectasia and
exacerbated thermoregulation responses involving sympathetic cholinergic, afferent sensory, and prolonged vasodilation. The
inflammatory processes consist of immunologic, neurogenic, and vascular adhesion molecules-induced inflammation. In terms
of neurogenic rosacea, substance p and CGRP secreted from sympathetic cholinergic and afferent sensory nerves, and
molecules released from mast cells activate the hyperexcitable A-delta and C fibers carrying the stinging and burning
sensation. A multifaceted mechanism-targeted treatment is crucial to a better and longer improvement.
HUANG Hsin-Yu
Sunday, May 04, 2025 - from 10:30 to 11:30 101A LEVEL 1 (MANDARIN)
Session:
Updates in Molecular Diagnosis and Non-invasive Skin Diagnostic Tools
CLINICAL APPLICATIONS OF GENETIC STUDY IN DIAGNOSIS AND TREATMENT OF INHERITED SKIN
DISORDERS
Inherited skin disorders, such as epidermolysis bullosa (EB), are characterized by significant clinical and genetic
heterogeneity, posing diagnostic and therapeutic challenges. The advent of advanced genomic technologies, including
whole-exome sequencing (WES) and RNA sequencing (RNA-seq), has revolutionized the molecular diagnosis and treatment
landscape for these conditions. WES facilitates the identification of pathogenic variants in disease-associated genes, enabling
precise genetic diagnoses and the stratification of patients for targeted therapies. RNA-seq further complements these efforts
by uncovering transcriptional dysregulation, alternative splicing events, and gene expression profiles critical to understanding
disease mechanisms at the molecular level.
Gene therapy has emerged as a promising therapeutic modality for inherited skin disorders. In the context of EB, approaches
such as gentamicin read-through treatment, ex vivo gene editing, viral vector-mediated gene delivery, and CRISPR-based
genome correction aim to restore functional protein expression, such as type VII collagen, thereby addressing the underlying
genetic defects. Furthermore, transcriptomic studies have facilitated the development of expression-specific therapies,
including small molecules and biologic treat against aberrant transcriptomic functions.
The integration of genomic diagnostics with innovative therapeutic approaches represents a paradigm shift in the
management of inherited skin disorders, advancing the field toward precision medicine and improved patient outcomes.
HUNG Chih-Tsung
Sunday, May 04, 2025 - from 14:30 to 15:30 201ABC LEVEL 2
Session:
New Therapeutic Options for Dermatologic Diseases
BREAKING NEW GROUND: INVESTIGATIONAL THERAPEUTICS FOR ATOPIC DERMATITIS
This talk explores recent developments in atopic dermatitis treatments, focusing on newer therapies currently being

investigated. We'll start with a quick overview of established treatments—from common topicals like steroids and calcineurin
inhibitors to newer systemic options including biologics (dupilumab, tralokinumab) and JAK inhibitors.
We'll then look at emerging therapeutics targeting different pathways: agents targeting OX40/OX40L (amlitelimab,
rocatinlimab) that seem to maintain effectiveness even after stopping treatment; newer IL-4Ra blockers like
stapokibart/CM310 showing promising results; and medications specifically targeting itch such as nemolizumab (IL-31) and
difelikefalin for patients where itching is the dominant problem.
The presentation will highlight how treatment approaches are moving toward more personalized medicine, with biomarkers
potentially helping match specific patient types to the most appropriate therapies. We'll review interesting findings from recent
clinical trials and analyses comparing different treatment options.
Finally, we'll discuss practical considerations for treatment selection—factors that might help determine which therapy could
work best for different patients based on their symptoms, other health conditions, and treatment goals. This is an exciting time
of innovation in atopic dermatitis care!
IWATA Yohei
Saturday, May 03, 2025 - from 16:00 to 18:00 NORTH LOUNGE (ACDS) LEVEL
3
Session:
New Horizons in Dermatologic and Aesthetic Surgery
HIDRADENITIS SUPPURATIVA MANAGEMENT: FROM DIAGNOSIS TO OPTIMIZING SURGICAL AND
BIOLOGIC THERAPY
Hidradenitis suppurativa (HS) is a chronic, recurrent inflammatory skin disorder characterized by painful nodules, abscesses,
and sinus tract formation in apocrine gland-bearing areas. This presentation summarizes key diagnostic criteria and practical
assessment tools for HS, followed by a focused overview of treatment options. Emphasis will be placed on surgical
management, including wide excision and skin grafting, and the role of biologic therapy such as adalimumab in moderate to
severe cases. Through selected clinical cases, we will discuss how timely diagnosis and a combined treatment approach can
improve outcomes. This talk will provide dermatologic surgeons with concise, practical strategies for managing HS.
KAO Michael
Saturday, May 03, 2025 - from 16:00 to 18:00 102 LEVEL 1
Session:
Non-surgical Lifting / Thread Lifts: The Art and Science Behind (co-session with MIPS)
A PROBLEM-ORIENTED EVALUATION CHECKLIST AND TREATMENT ALGORITHM OF THREAD LIFT
Thread lift, a minimally invasive procedure for tissue repositioning, has gained popularity as an alternative to surgical facelift.
A structured evaluation using a problem-oriented checklist to address considerations prior to the procedure can minimize
staff's errors & enhance patients' safety. A treatment algorithm follows accordingly, providing a stepwise approach: diagnosing
the correct aging signs, applying corresponding methods, adverse event prevention & management, and organizing
scheduled follow-ups. By offering such a systemic framework, this approach aims to standardize thread lift protocols in order
to further optimize outcomes & minimize complications, advocating its adoption in clinical practice.
KIM Il-Hwan
Saturday, May 03, 2025 - from 09:00 to 10:00 NORTH LOUNGE (ACDS) LEVEL
3
Session:
My Technique/Journey in Dermatologic Surgery: Pearls from the Maestros
FROM NOVICE TO EXPERT: MASTERING THE ART OF SUTURING IN DERMATOLOGIC SURGERY
Suturing is a fundamental skill in dermatologic surgery, requiring precision, efficiency, and an understanding of wound healing
principles. This lecture will guide participants through the essential techniques of suturing, progressing from basic methods to
advanced closure techniques used in complex dermatologic procedures.
I begin with an overview of suture materials and needle types, followed by the selection of appropriate sutures for different
wound types. Emphasis will be placed on the edge eversion technique, a critical principle in achieving optimal wound healing
and minimizing scar depression. Key suturing techniques, including simple interrupted, running, vertical and horizontal
mattress, and subcuticular sutures, will be demonstrated with clinical insights on maximizing cosmetic and functional
outcomes.
In the advanced section, we will explore tension-relieving techniques, including buried sutures, pulleys, and alternative
methods such as ZipLine skin closure systems and the use of a urine catheter for horizontal suture approximation. These
approaches are particularly useful in high-tension wounds or anatomically challenging areas. Additionally, we will discuss
post-suturing scar minimization strategies, including the use of pulsed dye laser (PDL) and Fractional laser treatment after

stitch removal to reduce erythema and optimize scar remodeling, particularly for facial wounds. Through case-based
discussions, we will address common pitfalls and strategies to refine suturing skills, ultimately enhancing both efficiency and
patient satisfaction. Whether you are a novice building a strong foundation or an experienced surgeon seeking to perfect your
technique, this lecture will provide practical tips to elevate your suturing proficiency in dermatologic surgery.
KIM Il-Hwan
Saturday, May 03, 2025 - from 10:30 to 11:30 SOUTH LOUNGE (MANDARIN)
LEVEL 3
Session:
What's New and Challenging Cases in Dermatopathology
MY EXPERIENCE IN DIFFERENTIATING BENIGN AND MALIGNANT SKIN TUMORS
Accurate differentiation between benign and malignant skin tumors is a critical skill in dermatologic practice. In this lecture, I
will share insights and practical approaches developed over years of clinical experience and dermatologic surgery. One of the
key themes of this talk is the impact of clinical experience on diagnostic accuracy. The ability to detect subtle clues—whether
visual, tactile, or intuitive—varies significantly depending on the level of experience. While textbook descriptions and
histopathologic criteria form the foundation, seasoned clinicians often rely on a refined "clinical instinct" developed through
repeated exposure to challenging cases. Through selected clinical cases, I will illustrate diagnostic challenges and
demonstrate how the integration of clinical impression, dermoscopy, biopsy strategy, and, in some cases, therapeutic
diagnosis can inform decision-making.
Particular focus will be given to: Role of dermoscopy in sBCC diagnosis and treatment monitoring, ddx of nevus vs pBCC,
early diagnosis of acral melanoma, actinic keratosis/SCC in situ, etc.
This session will emphasize how clinical experience serves not only to supplement diagnostic tools, but also to guide
judgment when objective findings are unclear. It is designed for clinicians aiming to refine their diagnostic accuracy and to
appreciate how diagnostic skill evolves over time.
LEE Chih-Hung
Sunday, May 04, 2025 - from 10:30 to 11:30 101A LEVEL 1 (MANDARIN)
Session:
Updates in Molecular Diagnosis and Non-invasive Skin Diagnostic Tools
INTRODUCTION: APPLICATIONS OF DERMATOLOGICAL DIAGNOSIS BASED ON CUTTING-EDGE
SCIENTIFIC DEVELOPMENTS
Scientific advances, including genomic sequencing, multimodal imaging, and artificial intelligence, have brought several
cutting-edge noninvasive diagnostic tools for better clinical care and precise medicine. Diseases that are considered urgent,
severe, rare, and intractable, pause a bunch of personal and social burdens. These cutting-edge diagnostic tools substantially
help clinicians provide better health cares to these patients in need. First, the talk will elaborate how next generation
sequencing for skin tissue helps the treatment dilemma of cutaneous T cell lymphoma (severe disease) versus eczematous
dermatitis. Second, the talk will show how the genomic studies help customize the treatments of inherited skin diseases (rare
disease). Third, the talk will show how advanced skin imaging coupled with deep learning to distinguish the heterogenous
pigmentary disorders (intractable), some of which require aggressive treatments promptly. Fourth, the talks will show the
functional and anatomic assessment of cutaneous microcirculation improves the diagnosis and treatment for some skin and
major systemic diseases (urgent diseases), which requires urgent interventions. This session bridges the scientific innovations
with the advanced medical care for diseases with huge burdens and suffering.
LEE Geun Soo
Sunday, May 04, 2025 - from 10:30 to 12:30 ELEGANCE LOUNGE LEVEL 4
Session:
Energy-based Devices : Exploring the New Frontier
DECENNIAL ANALYSIS REGARDING THE PIGMENTED AND DERMAL SENESCENCE TREATMENTS
Over the past four decades, laser-based skin rejuvenation therapies have undergone remarkable advancements. While
certain modalities have demonstrated consistent clinical efficacy and have been used for a long time, others have been
rendered ineffective due to recurring side effects. Pivotal concepts such as selective photothermolysis, extended theory of
selective photothermolysis, and fractional photothermolysis have been true game changers, fundamentally reshaping our
therapeutic approach. Additionally, technological evolution in radiofrequency (RF) and high-intensity focused ultrasound
(HIFU) devices has marked significant inflection points in the skin rejuvenation treatments. In this presentation, I want to share
insights drawn from long-term follow-up cases—spanning approximately a decade—of patients undergoing skin aging and
rejuvenation therapies, using them as references for new treatment approaches.

LEE Won
Saturday, May 03, 2025 - from 16:00 to 18:00 102 LEVEL 1
Session:
Non-surgical Lifting / Thread Lifts: The Art and Science Behind (co-session with MIPS)
UNUSUAL THREAD COMPLICATION AND PREVENTIONS
Thread lifting is one of the most commonly performed for minimally invaive lifting procedure. However there are multiple
complications including skin dimpling, parotid gland inflammation, and vascular complications. Using ultrasound can make the
procedure more safely.
LEE Leon Tsung-Ju
Saturday, May 03, 2025 - from 13:30 to 15:30 102 LEVEL 1
Session:
Emerging Injectables: What's New in Pipeline? All About Toxins, Fillers Stimulating Injectables
(co-session with AKD)
ADVANCING COLLAGEN BIOSTIMULATION: POSTTREATMENT MASSAGE AND COMPARATIVE ANALYSIS
OF POLYMERIC FILLERS IN AN ANIMAL MODEL
This presentation will introduce two preclinical studies involving collagen stimulators conducted in porcine models:
Study 1 investigates the effect of different post-injection massage techniques on the distribution of poly-L-lactic acid (PLLA).
Through animal modeling and histological analysis, the study demonstrates that a single immediate massage is sufficient to
achieve uniform distribution, potentially reducing the inconvenience and adverse events associated with prolonged massage.
These findings offer practical clinical evidence for optimizing PLLA injection protocols in aesthetic medicine.
Study 2 compares the collagen-stimulating effects of three biostimulatory fillers—PLLA, PDLLA, and PCL—using a porcine
model. Results indicate that PLLA most effectively induces and sustains type I collagen production, providing valuable clinical
insight for physicians in selecting the most appropriate treatment for skin regeneration.
LEE Leon Tsung-Ju
Sunday, May 04, 2025 - from 13:30 to 15:30 101A LEVEL 1 (MANDARIN)
Session:
From Bench to Bedside (by TSID)
UNRAVELING THE ROLE OF NON-CANONICAL NEDDYLATION OF TGFBR2 IN THE THERAPEUTIC
RESISTANCE, METASTASIS, AND IMMUNOSUPPRESSION OF MELANOMA AND DEVELOPING A
NEXT-GENERATION ANTICANCER STRATEGY
Background: BRAF V600E mutations drive melanoma progression and drug resistance. TGF-ß signaling contributes to this
process through TGFBR2 neddylation, preventing protein degradation. We investigated targeting TGFBR2 neddylation to
suppress metastasis and enhance BRAF inhibitor response. Methods: Gene Set Enrichment Analysis, site-directed
mutagenesis, MTT assays, migration and immunosuppression tests, and xenograft models were used to assess cellular and
tumor behaviors. Results: MLN4924 suppressed epithelial-mesenchymal transition and TGF-ß signaling. TGFBR2 knockdown
reduced migration and immunosuppression. Wild-type TGFBR2 restoration, but not neddylation-site mutants, recovered
cellular migration and drug resistance. Conclusion: Targeting TGFBR2 neddylation may combat melanoma.
LEE Hua-En
Sunday, May 04, 2025 - from 13:30 to 15:30 101A LEVEL 1 (MANDARIN)
Session:
From Bench to Bedside (by TSID)
EXPLORING THE SIGNALING PATHWAYS IN AUTOIMMUNE BULLOUS DISEASE
Pemphigus Vulgaris (PV) and Bullous pemphigoid (BP) are two most common autoimmune bullous diseases. Until now, PV
and BP patients still suffer from the side effects of steroid or potent immunosuppressant used to treat their disease. It's
important to develop a treatment balancing safety and efficacy. It has become interesting clear that acantholysis induced by
anti-desmoglein antibody in PV is an active process involving multiple signaling events. Work from our group had shown that
the inhibition of p38 MAPK could block pemphigus IgG induced cytoskeletal reorganization in tissue culture and blistering in
animal model. Our recent studies also identified that JAK3/STAT3 signaling pathway -mediated proinflammatory factors, such
as TARC and granzyme B, contributed to the pathogenesis of bullous pemphigoid. These research work provided the

rationale of a novel therapeutic approach for the treatment of autoimmune bullous diseases.
LI Hua-Jung
Sunday, May 04, 2025 - from 13:30 to 14:30 201ABC LEVEL 2
Session:
Exosome and Regenerative Medicine in Dermatology
EXOSOME IN REGENERATION AND CANCER
Exosomes enable communication between cells by transferring molecules. We found that stimulating the release of induced
exosomes (iExos) from stem cells triggers their transition to a non-stem cell state. When basal mammary epithelial stem cells
release iExos, they lose their stem cell traits. In contrast, when mammary luminal cells absorb these iExos, they acquire
basal-like stem cell properties and can generate mammary glands in vivo. This stemness transfer via iExos opens new
possibilities for regenerative medicine.
For example, the adult brain has limited ability to regenerate. As a result, injuries and neurodegenerative diseases often
cause lasting damage. Mesenchymal stem cells (MSCs), which can be isolated from adult tissues, have shown promise in
clinical trials. We discovered that MSC-derived exosomes triggered by an EP4 antagonist (GW-iExos) have significantly
improved therapeutic effects in treating central nervous system damage—including neuron loss, astrocyte hyperactivity,
inflammation, and blood-brain barrier disruption. In contrast, exosomes from untreated MSCs were far less effective against
such lesions, which are common in brain injury, stroke, Alzheimer's, and Parkinson's disease.
Similarly, breast cancer cells with a mesenchymal phenotype exhibit cancer stem cell (CSC) traits and resist chemotherapy.
By inducing iExo release, we can shift these cells from a mesenchymal/CSC state to a more epithelial, non-CSC state. This
process strips away CSC markers, mesenchymal markers, integrins, and drug efflux transporters, increasing the cells'
sensitivity to chemotherapy. This suggests that combining exosome inducers with standard treatment could effectively target
CSCs.
Finally, we found that tumor cells become more aggressive during progression by changing protein interactions that affect
how exosomal cargo—proteins and nucleic acids—is sorted. These discoveries have important implications for both
regenerative medicine and cancer therapy.
LIAO Yi-Hua
Saturday, May 03, 2025 - from 13:30 to 15:30 NORTH LOUNGE (ACDS) LEVEL
3
Session:
Dermatologic Aesthetic Surgery: Comprehensive and Concise Methods for Improving Your Results
(co-session TAFPRS/TSOPRS)
ADVANCES IN MELANOMA SURGERY: INTEGRATING NEOADJUVANT AND ADJUVANT TREATMENTS FOR
ENHANCED OUTCOMES
Radical surgery remains the cornerstone of melanoma treatment, with sentinel node biopsy serving as the standard method of
staging for patients with T1b tumors or greater. This staging technique provides critical information that informs the decision to
pursue adjuvant therapies, which may include checkpoint inhibitors (e.g., pembrolizumab, nivolumab) or targeted therapies
(e.g., BRAF and MEK inhibitors for BRAF-mutant melanoma). These therapies have been shown to significantly reduce the
risk of melanoma recurrence. Recent clinical trials of neoadjuvant immunotherapies, administered prior to surgery, have
demonstrated highly statistically significant improvements in event-free survival compared to standard adjuvant
immunotherapy in patients with macroscopic stage III melanoma. The combination of neoadjuvant and adjuvant therapies, in
conjunction with radical surgery, offers substantial potential to improve long-term survival outcomes, reduce relapse rates, and
optimize the management of melanoma.
LIN Jeng-Hsien
Sunday, May 04, 2025 - from 13:30 to 14:30 201ABC LEVEL 2
Session:
Exosome and Regenerative Medicine in Dermatology
ROSE STEM CELL DERIVED NANOPARTICLES FOR HAIR LOSS: MY CLINICAL EXPERIENCE
Hair loss is a main complaint in our dermatology clinic, especially androgenetic alopecia in both male and female patients .
Some topical and oral medication has been discovered to be beneficial to hair regrowth, with some side effects to different
degree. Exosomes, as signals between intercellular communication, have rapidly gained prominence in regenerative
medicine. Plant-derived exosomes represent an innovative alternative that addresses regulatory limitations imposed on

human-derived counterparts. In my presentation, I will demonstrate the clinical outcomes of rose stem cell-derived
extracellular nanoparticles for hair loss patients. I will also review current fundamental and clinical researches to elucidate the
possible mechanisms of action.
LO Yang
Saturday, May 03, 2025 - from 16:00 to 18:00 201ABC LEVEL 2
Session:
Updates in the Treatment of Psoriasis and Psoriatic Arthritis
EFFECT OF METABOLIC SYNDROME MANAGEMENT AND PSORIASIS
The higher prevalence of metabolic syndrome in patients with psoriasis than normal people is well known. Hypertension,
diabetes mellitus and dyslipidemia are common comorbidities. There are diverse effects of systemic therapies of metabolic
disorders in psoriasis. This speech mainly focus on the effect of metabolic syndrome management in psoriasis, including
lipid-lowering agents, antihypertensive drugs and antidiabetic drugs.
LU Sophie Pei-Hsuan
Sunday, May 04, 2025 - from 16:00 to 17:00 ELEGANCE LOUNGE LEVEL 4
Session:
Key Takeaways: Aesthetic Medicine Toolbox - Global Best Practices
COMBINATION OF SURGICAL AND NON-SURGICAL APPROACHES TO UNDER-EYE BAGS
With combination of lower blepharoplasty, fat grafting, thread lifting, injection of fillers, radiofrequency microneedling with
exosomes, I will showcase the clinical pearls and thinking process managing under-eye bags surgically and non-surgically.
LU Ting-Chen
Saturday, May 03, 2025 - from 13:30 to 15:30 201ABC LEVEL 2
Session:
Pediatric Dermatology
THE ROLE OF SURGERY IN THE MANAGEMENT OF PEDIATRIC CONGENITAL MELANOCYTIC NEVUS
This section will discuss about the surgical management for the pediatric congenital melanocytic nevus, especially on the
face.
LU Po-Hsuan
Sunday, May 04, 2025 - from 14:30 to 15:30 201ABC LEVEL 2
Session:
New Therapeutic Options for Dermatologic Diseases
EMERGING THERAPIES IN ALOPECIA
Alopecia treatment is evolving. Janus kinase (JAK) inhibitors show promise for alopecia areata via immune modulation. For
female pattern hair loss, finasteride and dutasteride are used with variable results, while bicalutamide offers a potential
alternative. FDA-approved low-level laser therapy activates follicles through red light and laser stimulation. This presentation
reviews current therapeutic mechanisms and clinical applications.
LUEANGARUN Suparuj
Saturday, May 03, 2025 - from 10:30 to 11:30 JOY LOUNGE LEVEL 4
Session:
It's All About Hair
EXOSOME THERAPY FOR HAIR REGROWTH AND REPIGMENTATION: A NOVEL APPROACH
Introduction:
Hair loss and hair depigmentation pose significant cosmetic and psychological concerns. Emerging evidence suggests that

exosome therapy, particularly from stem cell-derived sources (RSCEs), may promote hair regeneration and repigmentation
through mechanisms involving cell proliferation, melanogenesis, and anti-inflammatory pathways.
Objective:
To evaluate the efficacy of exosome therapy in hair regrowth and repigmentation and explore its potential role in combination
with energy-based devices (EBDs) such as fractional lasers and microneedling.
Materials and Methods:
A review of existing studies and clinical applications of exosome therapy for hair loss and repigmentation, including AGA,
poliosis circumscripta, and alopecia areata, was conducted. The focus included RSCE application via noninvasive
electroporation, microneedling, and fractional picosecond laser therapy. Various treatment protocols, patient responses, and
assessment methodologies were examined.
Results:
Patients demonstrated significant hair regrowth, with increased follicular density and diameter. Dermoscopic evaluation
revealed enhanced melanogenesis, with previously white hair shafts displaying proximal black coloring. No severe adverse
effects were reported, with only transient erythema and mild discomfort observed.
Discussion:
The findings suggest that exosome therapy promotes hair follicle stem cell activation, enhances Wnt/ß-catenin signaling, and
modulates melanocyte function. Fractional laser and microneedling facilitate exosome penetration and augment regenerative
effects. The combination of regenerative medicine with EBDs presents a minimally invasive alternative to traditional
pharmacologic treatments.
Conclusion:
Exosome therapy, particularly when combined with EBDs, offers a promising treatment modality for hair regrowth and
repigmentation. Further large-scale studies are warranted to optimize protocols and elucidate long-term efficacy.
MARINI Leonardo
Saturday, May 03, 2025 - from 14:30 to 15:30 JOY LOUNGE LEVEL 4
Session:
From Good to Great: Proven Strategies in Leadership, Media Management
HOW TO DEAL WITH BDD PATIENTS: EARLY RECOGNITION OF CLINICAL SIGNS AND SMOOTH EXIT
STRATEGIES
How to deal with BDD Patients: Early recognition of Clinical Signs and implementation of smooth exit strategies
Leonardo Marini, SDC The Skin Doctors' Center Trieste (I) Susanna Marini, MB BChBAO (UK) SDC The Skin Doctors' Center
Trieste (I) Leonardo.marini@skindoctors.it
Susanna.marini@skindoctors.it
Seeking dermatological treatments might hide variable degrees of psychological discomfort which have been enormously
amplified after Covid pandemic. Recognizing Body Dysmorfic Disorder (BDD) is crucial, especially when practicing in
cosmetic and aesthetic medical-surgical environmentswhere patients seek procedures to address perceived physical
alterations. BDD is characterized by excessiveconcern over imagined of minor defects, leading to significant personal distress
and behavioral impairment. Practitioners should be able to recognize key indicators of BDD such as: excessive preoccupation
with appearance of specific anatomical regions; psychiatric comorbidities such as depression, anxiety, obsessive-compulsive
disorder (OCD) or social phobia; altered behavioral equilibrium such as excessive grooming, exaggerated make-up, skin
picking and doctor shopping; emotional recognition deficits such as: misinterpretation of facial expressions leading to
exacerbation of social rejection. BDD is more prevalent in younger, female, and single individuals with rates ranging from
2.9% to 57%. Structured Clinical Interview and implementation of specific BDD questionnaires may be of help. Early detection
of BDD is the main goal to avoid unnecessary procedures and improve patient outcomes with the help of specialized mental
health specialists. Refrain from performing inappropriate procedures on frankly or suspected BDD patients often leads to
dissatisfaction and can exacerbate potentially aggressive behavior. The use of a preliminary checklist to document the
assessment of BDD symptoms and well-structured informed consents can protect practitioners from potential legal issues.
Gentle referring patients affected by suspected BDD to mental health professional such as cognitive-behavioral specialist for
appropriate treatment is of fundamental importance.
Seeking aesthetic and cosmetic improvements is not a good strategy to "cure" underlying psychological uneasiness and might
even worsen the original situation should results do not match patients' clinical expectations. Dermatologists are called to
improve their screening capabilities in order to recognize potentially problematic patient, borderline with BDD, and possibly
avoid treating them. This exercise is not always easy since many skillful dissimulators may fool even the most expert
practitioners,but all efforts should be implemented to spot even the most subtle signs of internal psychological pressure during
the initial interview. In rare cases cosmetic and aesthetic perception of personal body appearance by psychologically fragile
patients can even cause problems after simple diagnostic procedures such as a shave biopsy performed to rule out a possible
non-melanoma skin cancer. "Wounding" the unstable perceived aesthetic equilibrium of such patients can generate a
disproportionally aggressive reaction even if perfect healing processes have been assisted by proper explanatory instructions
and wound care. Personal professional charisma and innate emphatic attitude are very valuable weapons to defend ourselves
should controversies arise before or after cosmetic and aesthetic procedures.

Session:
AI and Technology in Dermatology
DIGITAL DERMATOLOGY ASSISTANT: OPPORTUNITIES AND CHALLENGES OF AI-ASSISTED CLINICAL
PRACTICE
As generative artificial intelligence (GenAI) rapidly rises and leads a new wave of innovation, various industries are seeking
opportunities for upgrading and transformation. The healthcare industry, in particular, urgently needs to respond to this
change. Dermatology clinical work is expected to enhance efficiency and accuracy through AI technology, addressing various
challenges in clinical practice.
Since 2024, Chung Shan Medical University Hospital successfully developed a highly integrated clinical data processing
platform using multimodal AI technology. This platform effectively integrates various data in clinical workflows, including
hospital information systems, various documents, voice, and images. Through no-code technology, medical personnel can
independently design and create their own assistants based on their needs, flexibly applying GenAI technology to optimize
workflows without altering existing systems.
In the field of dermatology, AI can assist doctors in quickly analyzing skin images, organizing patient data, providing
diagnostic suggestions, and even optimizing medical record writing, significantly improving the efficiency and quality of clinical
work. This speech will focus on how AI can assist dermatology clinical applications and explore the challenges and future
development directions that may be encountered in the process.
SHEN Chia-Ning
Sunday, May 04, 2025 - from 10:30 to 12:30 102 LEVEL 1
Session:
The Future is Now: Regenerative Medicine, Cell Therapies Microbiome (co-session TSSCR)
UNLOCKING THE POTENTIAL OF EXOSOMES GENERATED FROM INDUCED PLURIPOTENT STEM
CELL-DERIVED SKIN ORGANOIDS FOR WOUND HEALING
The frequency of chronic wounds is on the rise due to the growing prevalence of diabetes, vascular disease, and obesity. This
has resulted in cutaneous wound complications that contribute to clinical morbidity and mortality, impose an economic burden,
and cause emotional distress. stem cell-based therapies have be recognized as potential treatment options. Our previous
work implied a functional role for ABCG2 in the expansion and differentiation of p63-expressing epithelial stem/progenitor
cells. And ABCG2 deficiency in skin impairs re-epithelialization in cutaneous wound healing. We further showed
transplantation of epithelial stem cells can improve healing of chronic wounds. Recent studies also demonstrated the potential
of keratinocyte-derived exosomes to be applied on treating skin disorders. However, the inefficient and limited production of
exosomes has hampered their development for clinical translation. Here, we described an easy and optimized protocol to
produce functional keratinocyte-derived exosomes from human induced pluripotent stem cells (iPSCs). Self-organized
organoids generated from human iPSCs resemble complex skin tissues consisting of epidermis, dermis and pigmented hair
follicles. After 10 weeks of differentiation, the CK14+ cells were seen in the basal layer, whereas CK10 staining confirmed
formation of supra-basal layers. E-Cadherin+ epithelium were also detected. By day 120, CK17 staining indicates
development of outer root sheath of the hair follicles. The stimulatory effects on proliferation and migration of human dermal
fibroblast were observed after applying conditioned medium of iPSC-derived skin organoids to fibroblast culture. The
exosomes were further isolated from concentrated conditioned medium of iPSC-derived skin organoids followed by size
exclusion chromatography. These purified exosomes assessed by NTA and characterized by TEM were positive form CD9,
CD63 and CD81. We validated exosomes isolated from iPSC-derived skin organoids exerted similar effects in wound healing
assay. Further analysis of these purified exosome revealed enrichment of signaling regulator associated with
keratinocyte-fibroblast communication and signal transduction The findings of the current study reinforce the potential of
exosomes derived from iPSC-derived skin organoids can be used to improve wound healing.
SHIH Yi-Hsien
Saturday, May 03, 2025 - from 10:30 to 12:30 201ABC LEVEL 2
Session:
Acne and Rosacea - Think Outside the Box
UNLOCKING RETINOIDS: A PRACTICAL GUIDE FROM THE MEDICAL TREATMENT TO THE FUTURE OF
SKINCARE
Traditionally, acne vulgaris has been managed according to disease severity. However, evolving perspectives now emphasize
patient-centered factors, including quality of life and overall disease burden. Current consensus supports treatment strategies
that are adaptable—not only based on acne severity but also on psychosocial impact and long-term sequelae. The
Personalised Acne Treatment Tool (PATT) highlights important considerations such as truncal involvement and the presence
of acne sequelae, including scarring, post-inflammatory hyperpigmentation (PIH), and post-inflammatory erythema (PIE).
Retinoids remain central to acne management due to their comedolytic, anti-inflammatory, and anti-pigmentary properties.
This talk will explore their critical role in addressing both active acne and sequelae, with a focus on skin of color, particularly
Asian populations, who may be more prone to PIH and PIE. Additionally, treatment adherence continues to be a major clinical
challenge, often hindered by medication intolerance and irritation. Future directions in acne care should integrate

evidence-based skincare recommendations to mitigate adverse effects and improve long-term compliance. This
comprehensive approach—from pharmacologic therapy to adjunctive skincare—offers a more personalized and effective acne
management pathway.
SHIH Yi-Hsien
Saturday, May 03, 2025 - from 13:30 to 15:30 201ABC LEVEL 2
Session:
Pediatric Dermatology
PEDIATRIC ACNE MANAGEMENT: OPTIMIZING OUTCOME
Acne vulgaris is a common dermatologic condition that significantly impacts quality of life, particularly in pediatric patients. The
clinical presentation of acne differs between adolescents and adults, necessitating age-specific treatment approaches.
However, treatment options for pediatric patients are often limited due to age-related regulatory approvals and safety
concerns. In particular, the use of oral tetracyclines, isotretinoin, and hormonal therapy in younger patients raises specific
considerations regarding efficacy, safety, and long-term outcomes. This lecture will provide an updated review of current
evidence on these therapies, highlighting their benefits and potential risks in pediatric populations. Additionally, the talk will
explore how pediatric patients perceive acne, their understanding of the disease, and factors influencing their motivation to
seek treatment. Addressing these aspects is crucial for optimizing adherence and therapeutic success.
SHIH Yi-Hsien
Sunday, May 04, 2025 - from 14:30 to 15:30 201ABC LEVEL 2
Session:
New Therapeutic Options for Dermatologic Diseases
THE FUTURE OF ACNE: NOVEL THERAPIES AND THE RISE OF MICROBIOTA-FOCUSED SOLUTIONS
Acne vulgaris is a multifactorial inflammatory skin disorder involving follicular hyperkeratinization, excessive sebum
production, microbial dysbiosis, and aberrant immune responses. While conventional treatments—such as topical retinoids,
benzoyl peroxide, antibiotics, and hormonal therapy—have remained largely unchanged for decades, recent advances have
introduced novel therapeutic agents. Clascoterone, a topical androgen receptor inhibitor, and trifarotene, a selective retinoic
acid receptor-γ agonist, represent significant additions to the acne treatment armamentarium, offering improved
efficacy and tolerability. Concurrently, growing awareness of Cutibacterium acnes antibiotic resistance and
treatment-associated dysbiosis has shifted research focus toward microbiota-preserving strategies. Investigational therapies
targeting microbial biofilms and promoting a balanced skin microbiome are currently under development, aiming to reduce
inflammation while minimizing disruption to commensal flora. These microbiome-centered approaches are also being
translated into next-generation cosmeceuticals, reflecting the evolving paradigm in acne management. This presentation will
provide an overview of recently approved treatments and highlight emerging therapeutic strategies that align with precision
medicine and skin microbiome preservation.
SHIN Nala
Saturday, May 03, 2025 - from 13:30 to 15:30 ELEGANCE LOUNGE LEVEL 4
Session:
Anti-aging in the Era of Aesthetics (Co-session with AMWC Japan)
THE INSIDE-OUT APPROACH TO AGING SKIN
As we address aging skin, it is essential not only to apply cutaneous treatments but also to consider the systemic
physiological changes that accompany aging. In this lecture, I will present an 'inside-out' approach to managing aging skin,
grounded in current evidence on the gut-skin axis and the role of advanced glycation end products (AGEs). Emphasis will be
placed on lifestyle modification (LSM) strategies—including targeted dietary and behavioral interventions—designed to
optimize gut health and reduce systemic inflammation. This holistic, integrative approach aims to enhance both the efficacy
and longevity of aesthetic and dermatological interventions for aging skin.
SHIN Nala
Saturday, May 03, 2025 - from 13:30 to 15:30 ELEGANCE LOUNGE LEVEL 4

Session:
Anti-aging in the Era of Aesthetics (Co-session with AMWC Japan)
THE ROLE OF SENOTHERAPEUTICS IN MY WELL-AGING APPROACH
Senotherapeutics represent a broad spectrum of interventions designed to delay, prevent, or reverse age-related cellular
changes and their downstream effects, particularly those associated with the senescence-associated secretory phenotype
(SASP). These strategies include not only pharmacological agents and botanical compounds with anti-aging potential, but
also encompass exosomes, skin boosters, energy-based devices (EBDs), and comprehensive lifestyle interventions—such as
nutritional therapies and immune modulators targeting immunosenescence.
In this lecture, I will present the view that skin aging is not merely a localized process but a visible indicator of systemic aging.
The talk will highlight the integration of senotherapeutic strategies into my well-aging protocols, with the synergistic use of
EBD modalities.
SHIN Dongyun
Saturday, May 03, 2025 - from 13:30 to 15:30 102 LEVEL 1
Session:
Emerging Injectables: What's New in Pipeline? All About Toxins, Fillers Stimulating Injectables
(co-session with AKD)
LIPOLYTIC INJECTIONS FOR FACIAL CONTOURING IN KOREA: COCKTAIL FORMULATIONS, INJECTION
TECHNIQUES AND COMBINATION TREATMENT WITH BOTULINUM TOXIN
In Korea, Lipobin (phosphatidylcholine/deoxycholate), previously known as PPC injection, was widely used for fat reduction
(lipolysis), but had its approval revoked in 2014. Since then, several deoxycholate products have been introduced to the
market. However, lipolytic injections (fat-dissolving injections), used as off-label cocktail therapies, continue to be widely
practiced in the field in Korea. This lecture will focus on these lipolytic injections, commonly referred to as "fat-dissolving
injections' or "contour injections,' rather than the deoxycholate products that have been frequently discussed in recent
presentations.
Facial fat changes with aging. While deep fat compartments tend to lose volume, superficial fat shifts downward due to
gravity, leading to increased volume and sagging in the lower compartments. Common areas where volume increases and
sagging occur include the jowl fat, nasolabial fat and submental fat.
While various treatments, such as energy-based devices (EBD) and thread lifting, are used to "lift' sagging fat, targeting fat
reduction itself may be more effective in some cases. Moreover, combining lipolytic injections with other treatments often
leads to higher patient satisfaction.
Lipolytic injections are referred to by different names depending on the clinic, and the agents and cocktail formulations used
vary as well. This lecture will cover the types of agents that can be used for lipolytic injections in Korea, along with their
indications and treatment techniques, and approaches to combining them with energy-based devices (EBD) or botulinum toxin
for enhanced results.
SHIN Ji Yeoun
Saturday, May 03, 2025 - from 13:30 to 15:30 102 LEVEL 1
Session:
Emerging Injectables: What's New in Pipeline? All About Toxins, Fillers Stimulating Injectables
(co-session with AKD)
COMBINATION TREATMENT OF FILLER AND BIOSTIMULATOR FOR PERIORAL REJUVENATION
Skin boosters have become a key part of dermatologic treatments, and it is now hard to find an area where they are not used.
In recent years, we have seen a rapid increase in the number and types of skin boosters and biostimulators available. While
biostimulators are effective for skin rejuvenation by helping restore the extracellular matrix (ECM), including collagen and
elastin, they also have some limitations — especially when it comes to delicate areas like the lips or under the eyes.
This is why a multi-layered, multi-approach treatment strategy is essential to achieve optimal skin quality. Combining different
tools allows us to target both deep and superficial layers of the skin in a more precise and customized way.
In this presentation, I will focus on using both fillers and biostimulators to improve the lips, perioral area, and lower face.
Clinical approaches and practical tips for effective rejuvenation in these areas will be discussed.
SHIN Ji Yeoun
Sunday, May 04, 2025 - from 16:00 to 17:00 ELEGANCE LOUNGE LEVEL 4

Session:
Key Takeaways: Aesthetic Medicine Toolbox - Global Best Practices
TAILORED SKIN LAYER TARGETING FOR DIFFERENT SCAR TYPES USING NEEDLE-FREE JET INJECTOR
In this insightful lecture, I will introduce one of the most talked-about devices in Korea's aesthetic field today — the
Needle-Free Jet Injector (NFJI). This cutting-edge device delivers medication into the skin without the use of needles, offering
a revolutionary alternative for both patients and practitioners. I will explain how the NFJI works, how to adjust its levels to
target different skin layers, and why it is especially effective for treating stubborn, treatment-resistant scars. Additionally, we
will explore its role in skin rejuvenation procedures targeting the papillary dermis, where it offers the dual benefit of minimal
downtime and increased treatment speed.
SOCHAROENTAM Kamphon
Sunday, May 04, 2025 - from 13:30 to 15:30 PLENARY HALL LEVEL 3
Session:
From Precision to Perfection: Lower face, Jawline Neck
ART SCIENCE OF LIP ENHANCEMENT: ACHIEVING NATURAL BALANCE
Background:
Lip enhancement has evolved beyond volume augmentation to embrace a more holistic approach that combines scientific
understanding with artistic finesse. Achieving natural-looking results requires mastery of anatomy, injection technique, product
selection, and an aesthetic eye attuned to facial harmony.
Objective:
To explore the integration of scientific principles and artistic judgment in modern lip enhancement, with an emphasis on
achieving natural balance that respects individual ethnic characteristics, facial proportions, and dynamic expression.
Methods:
This presentation draws on clinical experience, anatomical insights, and case-based analysis to illustrate techniques for lip
enhancement that prioritize natural outcomes. Key elements include assessment of perioral structures, ideal lip ratios, product
rheology, and individualized treatment planning based on age, gender, and cultural aesthetics.
Results:
Strategic, layer-specific placement using soft, elastic fillers such as hyaluronic acid allows for subtle definition, contour
refinement, and hydration without distortion. When guided by facial anatomy and aesthetic balance—rather than trends or
volume targets—lip enhancement yields high patient satisfaction and long-lasting, harmonious results.
Conclusion:
The art and science of lip enhancement lie in achieving a balance between technique and intuition. By combining
evidence-based practice with artistic judgment, practitioners can deliver elegant, natural lips that enhance beauty while
preserving individuality.
SOFRA Xanya
Saturday, May 03, 2025 - from 13:30 to 15:30 ELEGANCE LOUNGE LEVEL 4
Session:
Anti-aging in the Era of Aesthetics (Co-session with AMWC Japan)
THE COLLAGEN MIRACLE AND WHY IT'S NOT ENOUGH FOR YOUTHFUL REJUVENATION
The Collagen Miracle and why it's not Enough for Youthful Rejuvenation
This presentation is based on a metanalysis of several scientific articles. All traumatic procedures increase collagen. Collagen
is the scar developing over a healing wound. Excessive production of collagen results in keloids. Since open injuries are
hideous. large laser and RF corporations invented the "invisible wound" that is formed under the surface of the skin. They
succeeded in contriving a method of forcing the body to increase its collagen in a certain area, but without investigating
whether the collagen increase at the treatment site was accompanied by deficient amounts of collagen in neighboring areas.
Trauma-based treatments never tested the null hypothesis as they should, according to validity and reliability principles. They
never examined if there is a systemic collagen deficiency in areas other than those receiving the laser or RF treatment. Their
counterargument would probably be: "Let's laser and RF more areas!" Forgetting that collagen increase depends on the
body's supplies and capacity to produce the collagen. If the body was unable to supply this protein lasers and RF would
increase nothing! The glorification of "collagen" has rendered it synonymous with youth maintenance. There are 7 types of
collagen involved in skin integrity and 18,127 proteins determine the age of the human epidermis only. Around 8,987 proteins
control the outer epidermis, and the stratum corneum, and 9,140 proteins are the brains of the inner epidermis, comprising

cell layers down to the basal membrane. Overall, collagen is 1/18,127 proteins on the human epidermis only and 1/100,000
proteins in the entire body.
Importantly, one cannot have true rejuvenation without proteostasis: the balance of proteins within their optimal range and
their harmonious interactions. Proteostasis is what determines aging and disease. Hormones are proteins and the deleterious
effects of hormonal imbalance have been widely explored and are well known.
Proteostasis is the dynamic regulation of a balanced/functional proteome. Aging is the loss of protein homeostasis. The body
cannot produce collagen because of the inefficient protein-to-protein communications and the systematic unfolding of proteins
that renders proteins non-functional interfering with the instructions necessary for the body repair mechanisms to produce new
collagens. The proteostasis network includes competing and integrated biological pathways within cells that control:
* biogenesis
* protein folding
* protein trafficking
* protein degradation.
A number of cellular processes are necessary for true antiaging. These include metabolic, multicellular organismal processes,
extracellular structure organization, protein development and transport, catabolic events, and adequate cellular
communication and stimulus-response
This presentation is designed to unpack the Collagen miracle to see if the Emperor has no clothes. Hundreds of devices
market themselves as increasing the production of collagen forgetting that keloids are an excess of collagen. Collagen is a
protein like hormones are proteins and it is crucial for anti-aging doctors to understand collagen as one of thousands of other
proteins that need to interact optimally with other proteins in order to turn back the clock. Protein balance is the same as
hormonal balance. Without balance, the freshness and natural glow of youth are forever lost and patients look puffed up and
wrinkle-free, yet artificial. Importantly, they don't look younger because they don't have that freshness and natural glow of
youth, so most people around them can still guess their real age.
1. Jose Viña, Consuelo Borrás, Juan Gambini, Juan Sastre, Federico V. Pallardó (2005) Why females live longer than males?
Importance of the upregulation of longevity-associated genes by oestrogenic compounds, FEBS Letters, Volume 579, Issue
12, Pages 2541-2545, ISSN 0014-5793, https://doi.org/10.1016/j.febslet.2005.03.090.
2. Tang, W. Y., & Ho, S. M. (2007). Epigenetic reprogramming and imprinting in origins of disease. Reviews in Endocrine and
Metabolic Disorders, 8, 173-182.
3. Chang, A. L. S., Bitter Jr, P. H., Qu, K., Lin, M., Rapicavoli, N. A., & Chang, H. Y. (2013). Rejuvenation of gene expression
pattern of aged human skin by broadband light treatment: a pilot study. Journal of Investigative Dermatology, 133(2), 394-402.
https://doi.org/10.1038/jid.2012.287
4. Xu, J., Spitale, R. C., Guan, L., Flynn, R. A., Torre, E. A., Li, R., ... & Chang, A. L. S. (2016). Novel gene expression profile
of women with intrinsic skin youthfulness by whole transcriptome sequencing. PloS one, 11(11), e0165913.
https://doi.org/10.1371/journal.pone.0165913
5. Doctrow, S. R., Lopez, A., Schock, A. M., Duncan, N. E., Jourdan, M. M., Olasz, E. B., ... & Lazarova, Z. (2013). Anne Lynn
S. Chang, Patrick H. Bitter Jr, Kun Qu, Meihong Lin, Nicole A. Rapicavoli and Howard Y. Chang. Journal of Investigative
Dermatology, 133, 1691.
6. Babatz, T. D., Spear, E. D., Xu, W., Sun, O. L., Nie, L., Carpenter, E. P., & Michaelis, S. (2021). Site specificity
determinants for prelamin A cleavage by the zinc metalloprotease ZMPSTE24. Journal of Biological Chemistry, 296.
7. Babatz, T. D., Spear, E. D., Xu, W., Sun, O. L., Nie, L., Carpenter, E. P., & Michaelis, S. (2021). Site specificity
determinants for prelamin A cleavage by the zinc metalloprotease ZMPSTE24. Journal of Biological Chemistry, 296.
https://doi.org/10.1074/jbc.RA120.015792
8. Messner, M., Ghadge, S. K., Maurer, T., Graber, M., Staggl, S., Christine Maier, S., ... & Zaruba, M. M. (2020). ZMPSTE24
is associated with elevated inflammation and Progerin mRNA. Cells, 9(9), 1981. doi: 10.3390/cells9091981
9. Alfaro-Arnedo, E., López, I. P., Piñeiro-Hermida, S., Canalejo, M., Gotera, C., Sola, J. J., ... & Pichel, J. G. (2022). IGF1R
acts as a cancer-promoting factor in the tumor microenvironment facilitating lung metastasis implantation and progression.
Oncogene, 41(28), 3625-3639. https://doi.org/10.1038/s41388-022-02376-w
10. Dahlström, M., Nordvall, G., Sundström, E., Åkesson, E., Tegerstedt, G., Eriksdotter, M., & Forsell, P. (2019).
Identification of amino acid residues of nerve growth factor important for neurite outgrowth in human dorsal root ganglion
neurons. European Journal of Neuroscience, 50(9), 3487-3501. https://doi.org/10.1111/ejn.14513
11. Prencipe, G., Minnone, G., Strippoli, R., De Pasquale, L., Petrini, S., Caiello, I., ... & Bracci-Laudiero, L. (2014). Nerve
growth factor downregulates inflammatory response in human monocytes through TrkA. The Journal of Immunology, 192(7),
3345-3354. https://doi.org/10.4049/jimmunol.1300825
12. Nakamura, J., Aoyagi, S., Nanchi, I., Nakatsuka, S. I., Hirata, E., Shibata, S., ... & Oji, Y. (2009). Overexpression of
eukaryotic elongation factor eEF2 in gastrointestinal cancers and its involvement in G2/M progression in the cell cycle.
International journal of oncology, 34(5), 1181-1189.https://doi.org/10.3892/ijo_00000246
13. Deng, H., Wu, Y., & Jankovic, J. (2015). The EIF 4G1 gene and Parkinson's disease. Acta Neurologica Scandinavica,
132(2), 73-78. https://doi.org/10.1111/ane.12397
14. Panda, D. K., Bai, X., Zhang, Y., Stylianesis, N. A., Koromilas, A. E., Lipman, M. L., & Karaplis, A. C. (2022). SCF-SKP2
E3 ubiquitin ligase links mTORC1/ER stress/ISR with YAP activation in murine renal cystogenesis. The Journal of Clinical
Investigation, 132(24).
15. Goodier, J. L., Cheung, L. E., & Kazazian Jr, H. H. (2012). MOV10 RNA helicase is a potent inhibitor of retrotransposition
in cells. https://doi.org/10.1371/journal.pgen.1002941
16. Schutyser, E., Richmond, A., & Van Damme, J. (2005). Involvement of CC chemokine ligand 18 (CCL18) in normal and
pathological processes. Journal of leukocyte biology, 78(1), 14-26. https://doi.org/10.1189/jlb.1204712
17. Khalkhal, E., Rezaei-Tavirani, M., Zali, M. R., & Akbari, Z. (2019). The evaluation of laser application in surgery: a review
article. Journal of lasers in medical sciences, 10(Suppl 1), S104. 10.15171/jlms.2019.S18
18. Parnigoni, A., Caon, I., Moretto, P., Viola, M., Karousou, E., Passi, A., & Vigetti, D. (2021). The role of the multifaceted

long non-coding RNAs: A nuclear-cytosolic interplay to regulate hyaluronan metabolism. Matrix Biology Plus, 11,
100060.https://doi.org/10.1016/j.mbplus.2021.100060
19. Sun, P., Sun, L., Cui, J., Liu, L., & He, Q. (2020). Long noncoding RNA HAS2-AS1 accelerates non-small cell lung cancer
chemotherapy resistance by targeting LSD1/EphB3 pathway. American Journal of Translational Research, 12(3), 950.
20. Parnigoni, A., Caon, I., Moretto, P., Viola, M., Karousou, E., Passi, A., & Vigetti, D. (2021). The role of the multifaceted
long non-coding RNAs: A nuclear-cytosolic interplay to regulate hyaluronan metabolism. Matrix Biology Plus, 11, 100060.
21. Andersson, Gunnar (2016). "The Problem of the Empirical Basis in Critical Rationalism". In Shearmur, Jeremy; Stokes,
Geoffrey (eds.). The Cambridge Companion to Popper. Cambridge Companions to Philosophy. Cambridge, UK; New York:
Cambridge University Press. pp. 125-142. doi:10.1017/cco9781139046503.005. ISBN 978-1-139-04650-3. OCLC 925355415.
22. Goldspink, G., Scutt, A., Martindale, J., Jaenicke, T., Turay, L., & Gerlach, G. F. (1991). Stretch and force generation
induce rapid hypertrophy and myosin isoform gene switching in adult skeletal muscle. Biochemical Society Transactions,
19(2), 368-373. DOI: 10.1042/bst0190368
23. Goldspink, G. (1999). Changes in muscle mass and phenotype and the expression of autocrine and systemic growth
factors by muscle in response to stretch and overload. Journal of anatomy, 194(3), 323-334.
https://doi.org/10.1046/j.1469-7580.1999.19430323.x
24. Semsarian, C., Wu, M. J., Ju, Y. K., Marciniec, T., Yeoh, T., Allen, D. G., ... & Graham, R. M. (1999). Skeletal muscle
hypertrophy is mediated by a Ca2+-dependent calcineurin signalling pathway. Nature, 400(6744), 576-581
25. Hill, M., & Goldspink, G. (2003). Expression and splicing of the insulin?like growth factor gene in rodent muscle is
associated with muscle satellite (stem) cell activation following local tissue damage. The Journal of physiology, 549(2),
409-418. https://doi.org/10.1113/jphysiol.2002.035832
26. Yang, S. Y., & Goldspink, G. (2002). Different roles of the IGF-I Ec peptide (MGF) and mature IGF-I in myoblast
proliferation and differentiation. FEBS letters, 522(1-3), 156-160. DOI https://doi.org/10.1016/S0014-5793(02)02918-6
27. Yang, S., Alnaqeeb, M., Simpson, H., & Goldspink, G. (1996). Cloning and characterization of an IGF-1 isoform expressed
in skeletal muscle subjected to stretch. Journal of Muscle Research & Cell Motility, 17, 487-495.
https://doi.org/10.1007/BF00123364
28. McKoy, G., Ashley, W., Mander, J., Yang, S. Y., Williams, N., Russell, B., & Goldspink, G. (1999). Expression of insulin
growth factor?1 splice variants and structural genes in rabbit skeletal muscle induced by stretch and stimulation. The Journal
of physiology, 516(2), 583-592. DOI https://doi.org/10.1111/j.1469-7793.1999.0583v.x
29. Sofra, X. (2020) Gain without Pain: Beyond Sport Effortless Exercise Solutions. Journal of Aesthetic Nursing, 9, 202-210.
https://doi.org/10.12968/joan.2020.9.5.202 [Citation Time(s):1]
30. Sofra, X. and Lampe, N. (2020) Empowering the Woman: A Comprehensive Model of Sexual Anti-Ageing. Journal of
Aesthetic Nursing, 9, 118-127. https://doi.org/10.12968/joan.2020.9.3.118 [Citation Time(s):1]
31. Sofra, X. How to get rid of visceral fat: a randomised double-blind clinical trial. Journal of Aesthetic Nursing, 2020, 9(7):
268-275.DOI: https://doi.org/10.12968/joan.2020.9.7.268
32. Sofra, X. Gain without pain: beyond sport effortless exercise solutions. Journal of Aesthetic Nursing,2020, 9(5):
202-210.DOI: https://doi.org/10.12968/joan.2020.9.5.202
33. Sofra X. The Importance of Systemic Balance in Safeguarding Health: A Randomized Double-Blind Clinical Trial on VLDL,
Triglycerides, Free T3,Leptin, Ghrelin, Cortisol and Visceral Adipose Tissue. Health, 2020, 12(8).DOI:
https://doi.org/10.4236/health.2020.128078
34. Sofra, X., Badami, S. Adverse Effects of Sedentary Lifestyles: Inflammation, and High-Glucose Induced Oxidative
Stress-A Double Blind Randomized Clinical Trial on Diabetic and Prediabetic Patients. Health,2020, 12(08): 1029. Article
ID:102260, 20 pages DOI: https://doi.org/10.4236/health.2020.128076
35. Sofra, X., Lampe, N. Technological Advances in Accelerated Wound Repair and Regeneration. Health,2020, 12(7):
717-737.DOI: 10.4236/health.2020.127053
36. Sofra, X., Lampe, N. A Randomized Longitudinal Double-Blind Clinical Trial on Long-Term Neuropathic Symptomatology
Relief & Pain Analgesia.Health, 2020, 12(07): 738. ID:101363,12 pages DOI: 10.4236/health.2020.127054
37. Sofra, X., Badami, S. A Review of COVID-19 associated factors: CRP, Creatinine, Bilirubin, VLDL,HDL, Triglycerides,
Cortisol and Thyroid Function. J Endo Metabol Res, 2020, 1(2):
1-17.https://www.maplespub.com/webroot/files/A-Review-of-COVID19-associated-factors-CRP-Creatinine-Bilirubin-VLDL-HDL-Triglyceride
38. Sofra, X. Dynamics of Female Sexuality; Hidden Emotional Issues. Health, 2020, 12(6): 694-708.DOI:
10.4236/health.2020.126051
39. Sofra, X., Lampe, N. Empowering the woman: a comprehensive model of sexual anti-ageing. Journal of Aesthetic Nursing,
2020, 9(3): 118-127.DOI: https://doi.org/10.12968/joan.2020.9.3.118
40. Sofra, X. The Affinity between Obesity and COVID-19. J Endo Metabol Res, 2020, 1(2):
1-13.https://maplespub.com/webroot/files/The-Affinity-between-Obesity-and-COVID-19_1602748373.pdf
41. Sofra X, Badami S. A Review of COVID19 associated factors: CRP, Creatinine, Bilirubin, VLDL, HDL,Triglycerides,
Cortisol, and Thyroid Function.J Endo Metabol Res., 2020,
1(2):1-17.https://maplespub.com/article/A-Re-view-of-COVID19-associated-factors-CRP-Creatinine-Bilirubin-VLDL-HDL-Triglycerides-Corti
42. Sofra X (2022) Liver Repair of NAFLD patients, Following Effortless Exercise and the Possible Involvement of
Endogenous Stem Cells. Journal of Diabetes, Metabolic Disorders and Control
43. El Assar, M., Angulo, J., & Rodríguez-Mañas, L. (2013). Oxidative stress and vascular inflammation in ageing. Free
Radical Biology and Medicine, 65, 380-401. https://doi.org/10.1016/j.freeradbiomed.2013.07.003
44. Zhao, Y., Simon, M., Seluanov, A. et al (2023).. DNA damage and repair in age-related inflammation. Nat Rev Immunol
23, 75-89 https://doi.org/10.1038/s41577-022-00751-y
45. D De Magalhães, J. P., & Ocampo, A. (2022). Cellular reprogramming and the rise of rejuvenation biotech. Trends in
Biotechnology, 40(6), 639-642. OI:https://doi.org/10.1016/j.tibtech.2022.01.011
46. Sofra X (2021) Checkmate by a Protean Invisible Enemy. Lampert Pub.
47. Sofra X (2023) Liver Repair of NAFLD patients following effortless exercise. Journal of Diabetes, Metabolic Disorders and
Ccntrol. Volume 9, Issue 140, 41, 42, pp 36-47.
48. Sofra, X (2023) The long term effects of effortless exercise on hormonal balance and health. Journal of Diabetes,
Metabolic Disorders and Ccntrol. Volume 10, Issue 2, pp 86-91.
49. Sofra, X., & Lampe, N. (2020). Technological Advances in Accelerated Wound Repair and Regeneration. Health, 12(7),
717-737. DOI: 10.4236/health.2020.127053
50. Sofra, X., & Lampe, N. (2020). A Randomized Longitudinal Double-Blind Clinical Trial on Long-Term Neuropathic

Symptomatology Relief & Pain Analgesia. Health, 12(07), 738. http://creativecommons.org/licenses/by/4.0/
51. Kogure, A., Uno, M., Ikeda, T., & Nishida, E. (2017). The microRNA machinery regulates fasting-induced changes in gene
expression and longevity in Caenorhabditis elegans. Journal of Biological Chemistry, 292(27), 11300-11309. doi:
10.1261/rna.1703809
52. Connolly, P. H., Caiozzo, V. J., Zaldivar, F., Nemet, D., Larson, J., Hung, S. P., ... & Cooper, D. M. (2004). Effects of
exercise on gene expression in human peripheral blood mononuclear cells. Journal of applied physiology, 97(4), 1461-1469.
https://doi.org/10.1152/japplphysiol.00316.2004
53. Yang, J., Diaz, N., Adelsberger, J., Zhou, X., Stevens, R., Rupert, A., ... & Cosentino, L. M. (2016). The effects of storage
temperature on PBMC gene expression. BMC immunology, 17(1), 1-15. https://doi.org/10.1186/s12865-016-0144-1
54. Connolly, P. H., Caiozzo, V. J., Zaldivar, F., Nemet, D., Larson, J., Hung, S. P., ... & Cooper, D. M. (2004). Effects of
exercise on gene expression in human peripheral blood mononuclear cells. Journal of applied physiology, 97(4), 1461-1469.
https://doi.org/10.1152/japplphysiol.00316.2004
55. Zuk, P. A., Zhu, M. I. N., Mizuno, H., Huang, J., Futrell, J. W., Katz, A. J., ... & Hedrick, M. H. (2001). Multilineage cells
from human adipose tissue: implications for cell-based therapies. Tissue engineering, 7(2), 211-228.
https://doi.org/10.1089/107632701300062859
56. Dayan, C.M.; Panicker, V. Hypothyroidism and depression. Eur. Thyroid J. 2013, 2, 168-179.
https://doi.org/10.1159/000353777
57. Wiersinga, W.M. Therapy of endocrine disease: T4 + T3 combination therapy: Is there a true effect? Eur. J. Endocrinol.
2017, 177, 287-296. http://www.ncbi.nlm.nih.gov/pubmed/28855267
58. Bathla, M.; Singh, M.; Relan, P. Prevalence of anxiety and depressive symptoms among patients with hypothyroidism.
Indian J. Endocrinol. Metab. 2016, 20, 468-474. http://www.ncbi.nlm.nih.gov/pubmed/27366712
59. Vita, R.; Mazzi, V.; Antonelli, A.; Benvenga, S. Antithyroid medications and psychosis. Expert Opin. Drug Saf. 2013, 12,
865-872. https://doi.org/10.1517/14740338.2013.823397
60. Romero-Gómez, B., Guerrero-Alonso, P., Carmona-Torres, J. M., Notario-Pacheco, B., & Cobo-Cuenca, A. I. (2019).
Mood disorders in levothyroxine-treated hypothyroid women. International journal of environmental research and public
health, 16(23), 4776
61. Wu, E.L.; Chien, I.C.; Lin, C.H.; Chou, Y.J.; Chou, P. (2013) Increased risk of hypothyroidism and hyperthyroidism in
patients with major depressive disorder: A population-based study. J. Psychosom. Res. 2013, 74, 233-237.
http://www.ncbi.nlm.nih.gov/pubmed/23438714)
62. Farmer, A.; Korszun, A.; Owen, M.J.; Craddock, N.; Jones, L.; Jones, I. Medical disorders in people with recurrent
depression. Br. J. Psychiatry 2008, 192, 351-355. https://doi.org/10.1192/bjp.bp.107.038380
63. Radhakrishnan, R.; Calvin, S.; Singh, J.K.; Thomas, B.; Srinivasan, K. Thyroid dysfunction in major psychiatric disorders
in a hospital based sample. Indian J.Med. Res. 2013, 138, 888-893
64. Bathla, M.; Singh, M.; Relan, P. Prevalence of anxiety and depressive symptoms among patients with hypothyroidism.
Indian J. Endocrinol. Metab. 2016, 20, 468-474. https://doi.org/10.4103/2230-8210.183476
65. Siegman, E. M. Muller H. H, Q; Luecke, C. Philipsen, A. Kornhuber. J.; Gromer, T. W. (2018) Association of depression
and ansiety disorders wit autoimmune thryroiditis. A systemic review and metalanalysis JAMA Psychtiatry, 75, 577-584
66. Larisch, R., Kley, K., Nikolaus, S., Sitte, W., Franz, M., Hautzel, H., ... & Müller, H. W. (2004). Depression and anxiety in
different thyroid function states. Hormone and metabolic research, 36(09), 650-653
67. Ittermann, T., Völzke, H., Baumeister, S.E. et al. Diagnosed thyroid disorders are associated with depression and anxiety.
Soc Psychiatry Psychiatr Epidemiol 50, 1417-1425 (2015). https://doi.org/10.1007/s00127-015-1043-
68. Wiersinga, W.M.(2017) Therapy of endocrine disease: T4 + T3 combination therapy: Is there a true effect? Eur. J.
Endocrinol. 177, 287-296. http://www.ncbi.nlm.nih.gov/pubmed/28855267
69. Panicker, V.; Evans, J.; Bjoro, T.; Asvold, B.O.; Dayan, C.M.; Bjerkeset, O. (2009) A paradoxical difference in relationship
between anxiety, depression and thyroidfunction in subjects on and not on T4: Findings from the HUNT study. Clin.
Endocrinol. 71, 574-580 https://doi.org/10.1111/j.1365-2265.2008.03521.x
70. Romero-Gómez, B., Guerrero-Alonso, P., Carmona-Torres, J. M., Notario-Pacheco, B., & Cobo-Cuenca, A. I. (2019).
Mood disorders in levothyroxine-treated hypothyroid women. International journal of environmental research and public
health, 16(23), 4776.
71. Giynas Ayhan, M.; Uguz, F.; Askin, R.; Gonen, M.S. The prevalence of depression and anxiety disorders in patients with
euthyroid Hashimoto's thyroiditis: A comparative study. Gen. Hosp. Psychiatry 2014, 36, 95-98.
https://doi.org/10.1016/j.genhosppsych.2013.10.002
72. Boudarene, M., Legros, J. J., & Timsit-Berthier, M. (2002). Study of the stress response: role of anxiety, cortisol and
DHEAs. L'encephale, 28(2), 139-146.
73. Tang, J., Chen, L. R., & Chen, K. H. (2021). The Utilization of dehydroepiandrosterone as a sexual hormone precursor in
premenopausal and postmenopausal women: An overview. Pharmaceuticals, 15(1), 46. doi: 10.3390/ph15010046
74. Villareal D.T., Holloszy J.O. DHEA enhances effects of weight training on muscle mass and strength in elderly women and
men. Am. J. Physiol. Endocrinol. Metab. 2006;291:E1003-E1008. doi: 10.1152/ajpendo.00100.2006.
75. Khorram O. DHEA: A hormone with multiple effects. Curr. Opin. Obstet. Gynecol. 1996;8:351-354. doi:
10.1097/00001703-199610000-00006.
76. McHenry, J., Carrier, N., Hull, E., & Kabbaj, M. (2014). Sex differences in anxiety and depression: role of testosterone.
Frontiers in neuroendocrinology, 35(1), 42-57. https://doi.org/10.1016/j.yfrne.2013.09.001
77. Giltay, E. J., Enter, D., Zitman, F. G., Penninx, B. W., van Pelt, J., Spinhoven, P., & Roelofs, K. (2012). Salivary
testosterone: associations with depression, anxiety disorders, and antidepressant use in a large cohort study. Journal of
psychosomatic research, 72(3), 205-213. https://doi.org/10.1016/j.jpsychores.2011.11.014
78. Barrett-Connor, E., von Mühlen, D. G., & Kritz-Silverstein, D. (1999). Bioavailable testosterone and depressed mood in
older men: the Rancho Bernardo Study. The Journal of Clinical Endocrinology & Metabolism, 84(2), 573-577.
79. Seidman, S. N. (2003). Androgens, Erectile Dysfunction, and Depression. J Clin Psychiatry, 64(10), 31-37.
80. Bolour, S., & Braunstein, G. (2005). Testosterone therapy in women: a review. International journal of impotence research,
17(5), 399-408.
81. Hintikka, J., Niskanen, L., Koivumaa-Honkanen, H., Tolmunen, T., Honkalampi, K., Lehto, S. M., & Viinamäki, H. (2009).
Hypogonadism, decreased sexual desire, and long-term depression in middle-aged men. The journal of sexual medicine, 6(7),
2049-2057.
82. Araujo, A. B., Durante, R., Feldman, H. A., Goldstein, I., & McKinlay, J. B. (1998). The relationship between depressive

symptoms and male erectile dysfunction: cross-sectional results from the Massachusetts Male Ageing Study. Psychosomatic
medicine, 60(4), 458-465.
83. Skoluda, N., Dettenborn, L., Stalder, T. and Kirschbaum, C. (2012) Elevated Hair Cortisol Concentrations in Endurance
Athletes. Psychoneuroendocrinology, 37, 611-617. https://doi.org/10.1016/j.psyneuen.2011.09.001
84. Sofra, X., & Badami, S. (2020). A Review of COVID-19 associated factors: CRP, Creatinine, Bilirubin, VLDL, HDL,
Triglycerides, Cortisol and Thyroid Function. J Endo Metabol Res, 1(2), 1-17.
https://maplespub.com/article/A-Review-of-COVID19-associated-factors-CRP-Creatinine-Bilirubin-VLDL-HDL-Triglycerides-Cortisol-and-Th
85. Sofra, X., & Badami, S. (2020). Adverse effects of sedentary lifestyles: Inflammation, and high-glucose induced oxidative
stress—A double-blind randomized clinical trial on diabetic and prediabetic patients. Health, 12(08), 1029.
http://creativecommons.org/licenses/by/4.0/
86. Sofra, X. (2020). The Importance of Systemic Balance in Safeguarding Health: A Randomized Double-Blind Clinical Trial
on VLDL, Triglycerides, Free T3, Leptin, Ghrelin, Cortisol and Visceral Adipose Tissue. Health, 12(08), 1067.
http://creativecommons.org/licenses/by/4.0/
87. Sofra, X. (2020). How to get rid of visceral fat: a randomised double-blind clinical trial. Journal of Aesthetic Nursing, 9(7),
268-275. https://doi.org/10.12968/joan.2020.9.7.268
88. Lavie, C.J., Ozemek, C., Carbone, S., Katzmarzyk, P.T. and Blair, S.N. (2019) Sedentary Behavior, Exercise, and
Cardiovascular Health. Circulation Research, 124, 799-815. https://doi.org/10.1161/CIRCRESAHA.118.312669
89. Kaminsky, L.A., Arena, R., Ellingsen, O., Harber, M.P., Myers, J., Ozemek, C. and Ross, R. (2019) Cardiorespiratory
Fitness and Cardiovascular Disease—The Past, Present, and Future. Progress in Cardiovascular Diseases, 62, 86-93.
https://doi.org/10.1016/j.pcad.2019.01.002
90. Imboden, M.T., Harber, M.P., Whaley, M.H., Finch, W.H., Bishop, D.L., Fleenor, B.S. and Kaminsky, L.A. (2019) The
Association between the Change in Directly Measured Cardiorespiratory Fitness across Time and Mortality Risk. Progress in
Cardiovascular Diseases, 62, 157-162. https://www.ncbi.nlm.nih.gov/pubmed/30543812
91. Ozemek C., Laddu, D.R. and Lavie C.J. (2018) An Update on the Role of Cardiorespiratory Fitness, Structured Exercise
and Lifestyle Physical Activity in Preventing Cardiovascular Disease and Health Risk. Progress in Cardiovascular Diseases,
61, 484-490. https://doi.org/10.1016/j.pcad.2018.11.005
92. Hill, E.E., Zack, E., Battaglini, C., Viru, M., Viru, A. and Hackney, A.C. (2008) Exercise and Circulating Cortisol Levels: The
Intensity Threshold Effect. Journal of Endocrinological Investigation, 31, 587-591. https://doi.org/10.1007/BF03345606
93. Pedersen, B.K., Steensberg, A. and Schjerling, P. (2001) Muscle-Derived Interleukin-6: Possible Biological Effects. The
Journal of Physiology, 536, 329-337. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2278876
94. Grossmann, M. (2011) Low Testosterone in Men with Type 2 Diabetes: Significance and Treatment. The Journal of
Clinical Endocrinology & Metabolism, 96, 2341-2353. https://doi.org/10.1210/jc.2011-0118
95. Shores, M.M., Moceri, V.M., Sloan, K.L., Matsumoto, A.M. and Kivlahan, D.R. (2005) Low Testosterone Levels Predict
Incident Depressive Illness in Older Men: Effects of Age and Medical Morbidity. The Journal of Clinical Psychiatry, 66, 7-14.
https://doi.org/10.4088/JCP.v66n0102
96. Lua, I., James, D., Wang, J., Wang, K. S., & Asahina, K. (2014). Mesodermal mesenchymal cells give rise to
myofibroblasts, but not epithelial cells, in mouse liver injury. Hepatology, 60(1), 311-322. https://doi.org/10.1002/hep.27035
97. Tremolada, C., Colombo, V., & Ventura, C. (2016). Adipose tissue and mesenchymal stem cells: state of the art and
Lipogems® technology development. Current stem cell reports, 2(3), 304-312. https://doi.org/10.1007/s40778-016-0053-5
98. Strem, B. M., Hicok, K. C., Zhu, M., Wulur, I., Alfonso, Z., Schreiber, R. E., ... & Hedrick, M. H. (2005). Multipotential
differentiation of adipose tissue-derived stem cells. The Keio journal of medicine, 54(3), 132-141.
https://doi.org/10.2302/kjm.54.132
99. Banas, A., Teratani, T., Yamamoto, Y., Tokuhara, M., Takeshita, F., Quinn, G., ... & Ochiya, T. (2007). Adipose
tissue?derived mesenchymal stem cells as a source of human hepatocytes. Hepatology, 46(1), 219-228
https://doi.org/10.1002/hep.21704
100. Van Poll, D., Parekkadan, B., Borel Rinkes, I. H. M., Tilles, A. W., & Yarmush, M. L. (2008). Mesenchymal stem cell
therapy for protection and repair of injured vital organs. Cellular and Molecular Bioengineering, 1(1), 42-50.
https://doi.org/10.1007/s12195-008-0001-2
101. Esrefoglu, M. (2013). Role of stem cells in repair of liver injury: experimental and clinical benefit of transferred stem cells
on liver failure. World journal of gastroenterology: WJG, 19(40), 6757. 2013 Oct 28;19(40):6757-73. doi:
10.3748/wjg.v19.i40.6757. PMID: 24187451; PMCID: PMC3812475

SUN Pei-Lun
Saturday, May 03, 2025 - from 16:00 to 18:00 SOUTH LOUNGE (MANDARIN)
LEVEL 3
Session:
Challenges in Nail Diseases
ONYCHOMYCOSIS CAUSED BY UNCOMMON FUNGAL PATHOGENS
Dermatophytes are the primary pathogens of onychomycosis. However, there are still many fungi with keratinolytic activity
that can cause nail infections. The prevalence of non-dermatophyte mould onychomycosis (NDM OM) varies by region,
ranging from 1.8% to 23.5% (average 6.9%). The pathogens are highly diverse, mainly Aspergillus, Scopulariopsis, Fusarium,
Neoscytalidlium, etc. Because the pathogens of NDM OM are mostly environmental fungi, their clinical significance should be
carefully evaluated. Correct diagnosis can avoid unnecessary oral drug treatment or missing the true underlying diseases.
Diagnostic criteria include repeated isolation of the same pathogen (species level), identical repeated PCR results, and
evidence of nail invasion by histopathology. Response to treatment varies depending on the pathogen. The treatment duration
is longer than that of dermatophyte OM in general.
SUN Pei-Lun
Sunday, May 04, 2025 - from 17:00 to 18:00 201ABC LEVEL 2
Session:
Skin Infection and Infestation (Mandarin)
SKIN FUNGAL INFECTION FROM ANIMAL ORIGIN
Animals and humans share many of the same fungal infections. Some animal pathogens can cause human infection through
contact with sick animals or trauma. Microsporum canis is the most common zoonotic dermatophyte from cats and dogs.
However, along with the popularity of pet keeping and the diversity of exotic species, emerging pathogens are transported
between countries and have gradually appeared in Taiwan and neighboring Asian countries. Fungal culture and identification
are crucial tools for detecting zoonotic infections, playing a vital role in confirming the source of infection and interrupting the
transmission chain.
TAKENOUCHI Tatsuya
Saturday, May 03, 2025 - from 09:00 to 10:00 NORTH LOUNGE (ACDS) LEVEL
3
Session:
My Technique/Journey in Dermatologic Surgery: Pearls from the Maestros
MINIMALLY INVASIVE SURGERY FOR ELDERLY PATIENTS WITH SKIN CANCER
The number of elderly patients with skin cancer is rapidly increasing in Japan. In addition to minimally invasive treatment
tailored to each individual, awareness activities that encourage early medical visits are essential.
TANG Kuo-Tung
Saturday, May 03, 2025 - from 09:00 to 10:00 201ABC LEVEL 2
Session:
Drug Reaction (Drug Allergy Cancer Treatment-related Skin Reaction)
NSAIDS HYPERSENSITIVITY: MANIFESTATIONS, MECHANISMS AND PREVENTION
NSAID hypersensitivity is commonly encountered in clinical practice and potentially lethal. The various cutaneous
manifestations constitute the landscape of NSAID hypersensitivity. The mechanism underlying NSAID hypersensitivity has
been further explored in recent decades. The protocol for finding a safe alternative drug is well-established and clinically
applicable. It is my great pleasure to discuss such an important issue with dermatologists.
TEIXEIRA Danilo
Saturday, May 03, 2025 - from 11:30 to 12:30 JOY LOUNGE LEVEL 4

Session:
The Global Perspective: Gender, Culture Modern Aesthetic Practice
BRAZILIAN PERSPECTIVE BRAZILIAN TRENDS IN AESTHETICS
Brazil represents a unique and influential aesthetic market, shaped by cultural diversity, social media dynamics, and evolving
patient expectations. This presentation explores key aesthetic trends emerging in Brazil for 2025, emphasizing a movement
away from standardized volumization strategies such as MD Codes, and toward personalized, natural-looking outcomes.
The lecture highlights the growing preference for combination treatments integrating threads, biostimulators, regenerative
therapies, and energy-based devices (EBDs), particularly those aimed at facial slimming and contour refinement. Special
attention is given to the pathophysiological implications of excessive HA filler use, including its potential to induce
adipogenesis and contribute to "pillow face" syndrome.
New protocols leveraging second-generation HIFU, radiofrequency microneedling (RFM), and bipolar radiofrequency (BRF)
are presented as effective, technology-driven solutions for volume control and collagen remodeling. The increasing impact of
social media — notably the "Wow effect" and demand for one-day care procedures — is examined as a catalyst for the
popularity of minimally invasive treatments with rapid, visible results.
This session offers clinical insights into tailoring aesthetic strategies to contemporary patient profiles, combining innovation
with anatomical preservation and identity respect — the hallmark of modern Brazilian aesthetic practice.
THAITIRAROT Sirinan
Saturday, May 03, 2025 - from 09:00 to 10:00 101A LEVEL 1
Session:
Rising Star Forum
THE STUDY TO EVALUATE THE EFFICACY AND SAFETY OF POLY-D, L-LACTIC ACID HYBRID WITH
NON-CROSSLINKED HYALURONIC ACID INJECTION FOR FACIAL REJUVENATION IN ASIANS
Background/Objectives:
Background: Hybrid PDLLA biostimulator has gained interest in aesthetic field. Little is known about its biophysical effects on
skin and no established clinical study for reconstitution protocol.
Objective: To evaluate the efficacy and safety of Hybrid biostimulator composed of Poly-D, L-Lactic Acid (PDLLA) hybrid with
non-crosslinked hyaluronic acid utilizing novel reconstitution and injection protocol for facial rejuvenation in Asian.
Methods:
Thirty participants, with a mean age of 40.2 ± 7.21 underwent hybrid PDLLA (PDLLA 42.5 mg with HA 7.5 mg) reconstitute
with sterile water 6 cc and lidocaine 1.5 cc to make final of 7.5 cc solution and injecting in subdermal plane utilizing cannula
techniques (0.5 ml infraorbital, 0.25 ml crowfeet and 3 ml midcheek area per side) and hybrid PDLLA (PDLLA 170 mg hybrid
with HA 30 mg) reconstitute with sterile water 7 cc and lidocaine 1 cc to make final of 8 cc dilution and inject to nasolabial fold
1 cc per side. Three treatment sessions spaced 1 month apart were performed with Follow up visits at 2 weeks and 1, 3, 6, 9,
12 months after treatment. Skin biophysical properties were measured at each visit using the Cutometer®, Mexameter®,
Colorimeter®, Sebumeter®, and Antera®
Results:
Currently, patients were follow-up to 6th months after completed 3 sessions treatment, a statistically significant increase in the
skin R0 parameter, measured by Cutometer®, representing abilility of the skin to be streaching upward, was observed starting
from the 2nd treatment and continuing up to 6 months after the complete treatment (p-values = 0.002,
Conclusions:
The hybrid Poly-D,L-lactic acid injections demonstrated improvements in skin pliability and elasticity. Additionally, significant
reductions in depression volume were observed in the tear trough and nasolabial fold areas, along with decreased
pigmentation in the cheek and periorbital regions suggested its potential as an effective treatment option for facial
rejuvenation, reduce scar firmness, diminish pigmentation, as well as providing volumization in depressed areas and minimize
side effects.
TSAI Wen-Chien
Saturday, May 03, 2025 - from 09:00 to 10:00 JOY LOUNGE LEVEL 4
Session:
Cosmeceuticals/ Peelings/ Skin care
THE CONSIDERATIONS OF EMOLLIENTS IN PREGNANCY AND CHILDREN
Lotions and other moisturizing products are often recommended for dermatology patients. However, for certain special

populations such as pregnant women and children, the safety of specific ingredients in these products should be carefully
considered. These include hormone-like substances such as parabens and phthalates, as well as long-standing concerns
regarding the safety of functional ingredients like menthol, camphor, urea, and salicylic acid.
TSENG Han-Chi
Sunday, May 04, 2025 - from 10:30 to 12:30 201ABC LEVEL 2
Session:
Atopic Dermatitis
BIOLOGICS OR JAK INHIBITORS? HOW DO I SELECT SUITABLE TREATMENTS FOR AD PATIENTS?
The emergence of targeted therapy including biologics and JAK inhibitors has substantially level up the treatment standard for
patients with moderate to severe atopic dermatitis. The new drugs have greatly benefited the millions of patients and
caretakers worldwide. Whether to opt for biologics or oral JAK inhibitors is the choice we have to make with our patients in our
daily practice. This talk is to summarize the pros and cons of both biologics and JAK inhibitors The talk emphasizes on how to
choose in order to reach the optimal treatment response and bring out the greatest satisfaction from patients.
TSENG Jonathan Te-Peng
Saturday, May 03, 2025 - from 10:30 to 11:30 JOY LOUNGE LEVEL 4
Session:
It's All About Hair
THE APPLICATION OF REGENERATIVE MEDICINE IN THE TREATMENT OF ANDROGENETIC ALOPECIA
In androgenetic alopecia, hair follicle miniaturization is marked by a shorter anagen (growth) phase and an increased number
of follicles in the telogen (resting) phase, often producing microscopic hairs. Although the number of hair follicle stem cells
(HFSCs) remains unchanged in balding scalps, the population of actively proliferating progenitor cells significantly declines.
This has led to growing interest in using stem cells and exosomes as potential treatments for androgenetic alopecia.
TSENG Ming-Hseng
Saturday, May 03, 2025 - from 14:30 to 15:30 SOUTH LOUNGE (MANDARIN)
LEVEL 3
Session:
AI and Technology in Dermatology
EXPERIENCES IN THE APPLICATION OF AI FOR DERMATOLOGICAL IMAGE ANALYSIS AI
Sharing experiences on the application of AI technology in dermatological image analysis.
TSUBOUCHI Rieko
Saturday, May 03, 2025 - from 13:30 to 15:30 ELEGANCE LOUNGE LEVEL 4
Session:
Anti-aging in the Era of Aesthetics (Co-session with AMWC Japan)
LATEST OF REGENERATIVE AND ANTI-AGING MEDICINE
Facial aging is not merely a superficial concern—it reflects complex, multi-layered biological changes across the skin, fat,
muscle, and bone. Recent advances in genomic and epigenomic science, including the development of tissue-specific
epigenetic clocks and aging biomarkers, have deepened our understanding of how aging unfolds at the cellular level.
In this lecture, I will present clinically relevant insights into the mechanisms of facial aging, focusing on skin-level genomic and
epigenomic alterations, and briefly touching on deeper tissue layers. Against this biological backdrop, we will explore
regenerative treatment options such as PRP, stem cell-derived supernatants, and exosomes, discussing their roles,
limitations, and practical use in aesthetic medicine.
By understanding the cellular basis of aging, we can navigate aesthetic treatment choices with greater clarity—grounded in
biology, not marketing—toward a more integrated aesthetic approach.

WANG Chao-Chin
Sunday, May 04, 2025 - from 10:30 to 12:30 ELEGANCE LOUNGE LEVEL 4
Session:
Energy-based Devices : Exploring the New Frontier
PICOSECOND LASERS: REAL-WORLD BENEFITS AFTER A DECADE - IS THIS THE END OF THE STORY OR
JUST THE BEGINNING?
Over the past decade, since their FDA approval, picosecond lasers have significantly advanced aesthetic treatments,
particularly in tattoo removal and benign pigment reduction. This presentation will explore the real-world benefits these lasers
have brought to these procedures and their growing applications beyond pigment-based treatments. We will also delve into
the advancements in understanding laser-tissue interactions, especially with various fractional hand-pieces that have
improved treatment outcomes. However, the journey is far from complete, the pursuit of optimal clinical endpoints for even
greater precision continues, suggesting that the potential of picosecond lasers is still unfolding.
WANG Shiou-Han
Saturday, May 03, 2025 - from 09:00 to 10:00 ELEGANCE LOUNGE LEVEL 4
Session:
Energy-based Devices : Rethink the Basics and Untold Truth
OPTIMIZING RETURN ELECTRODE PLACEMENT IN MONOPOLAR RF FOR SAFETY AND EFFICACY: A
MATHEMATICAL AND PHYSICAL APPROACH
Optimizing Return Electrode Placement in Monopolar RF for Safety and Efficacy: A Mathematical and Physical Approach
Shiou-Han WANG
Abstract
Background:
Return electrode placement in monopolar radiofrequency (MRF) significantly influences thermal distribution, impedance
stability, and penetration depth. Clear guidelines remain lacking.
Objective:
To identify optimal return electrode placement for enhanced safety and efficacy in MRF treatments through mathematical and
physical analyses.
Methods:
Following a clinical incident involving a first-degree burn, theoretical models including electric field analysis, impedance
variation (IV), impedance variation rate (IVR), and penetration depth were utilized.
Results:
Close electrode placement (<0.2 m) increased localized heating and burn risks, while excessive distance (>0.5 m) decreased
therapeutic efficacy. Optimal placement at approximately 0.45 m balanced effective heating and safety.
Conclusion:
These findings are based on parameters from commonly used systems such as Thermage MRF. If device settings differ, all
calculations related to return electrode placement must be re-evaluated accordingly.
Placing the return electrode around 0.45 m from the treatment area on the back or abdomen provides the best balance of
safety and effectiveness. Further studies should validate these findings clinically.
WANG Shiou-Han
Sunday, May 04, 2025 - from 16:00 to 17:00 ELEGANCE LOUNGE LEVEL 4
Session:
Key Takeaways: Aesthetic Medicine Toolbox - Global Best Practices
THE BIOMECHANICS OF SAFETY: A QUANTITATIVE APPROACH TO VASCULAR-FREE FILLER INJECTIONS
This presentation proposes an innovative quantitative methodology to eliminate vascular complications associated with facial
filler injections. The approach integrates precise anatomical measurements, biomechanical modeling, and statistical analysis

to establish evidence-based injection protocols. Specifically, this quantitative framework includes:
Anatomical Quantification: Determining the calibers of facial arteries through detailed anatomical measurement and imaging
analysis, thus identifying thresholds critical for safe cannula selection.
Instrument Dimensional Analysis: Precisely calculate the diameters of blunt cannulas (e.g., 18-gauge) and correlate them to
facial arterial diameters to optimize instrument choice.
Biomechanical Modeling: Applying biomechanical principles to quantitatively assess the mechanical force exerted by blunt
cannulas on arterial walls, thereby defining safe operational thresholds to prevent vascular penetration and injury.
Statistical Risk Assessment: Conduct rigorous statistical modeling to calculate and predict the probability of vascular
complications using this new biomechanical approach, validating its efficacy in clinical settings.
By integrating anatomy, biomechanics, instrument engineering, and statistical validation, this quantitative approach provides
clinicians with robust, reproducible guidelines that effectively minimize the risk of vascular complications, ensuring consistently
safe and superior aesthetic outcomes.
WEI Chia-Hung
Saturday, May 03, 2025 - from 10:30 to 12:30 ELEGANCE LOUNGE LEVEL 4
Session:
Spotlight on Pigments: Mastering the Science and Cutting-edge Treatment (Co-session with DST)
ENCHANCING MICRONEEDLING RF RESULTS USING PLANT DERIVED EXOSOMES IN MELASMA
Melasma has always been a troublesome pigment disorder both to patients and clinicians. Microneedling RF has been proved
to treat melasma effectively. Plant-derived exosome has unique anti-inflammation and melonocyte modulation function, which
makes it a benificial role in combination with microneedling RF to treat melasma.
WU Jennifer
Saturday, May 03, 2025 - from 13:30 to 15:30 201ABC LEVEL 2
Session:
Pediatric Dermatology
MELANOCYTIC NEVI IN CHILDREN: CLINICAL FEATURES AND WHEN TO WORRY
This lecture will include the clinical features and dermoscopic findings of melanocytic nevi in children, and will discuss the risk
factors of malignant melanoma and concerning features that should prompt referaral to a dermatologic surgeon.
WU Jennifer
Saturday, May 03, 2025 - from 16:00 to 18:00 SOUTH LOUNGE (MANDARIN)
LEVEL 3
Session:
Challenges in Nail Diseases
EVALUATION, BIOPSY, AND MANAGEMENT OF LONGITUDINAL MELANONYCHIA
Longitudinal melanonychia is a common clinical finding with various benign and malignant etiologies. This lacture will include
the important clinical features and dermoscopic findings that should prompt referral to a dermatologic surgeon for a nail matrix
biopsy, the considerations and techniques of nail matrix biopsies and further management.
WU Nan-Lin
Saturday, May 03, 2025 - from 16:00 to 18:00 201ABC LEVEL 2
Session:
Updates in the Treatment of Psoriasis and Psoriatic Arthritis
TREATMENT OPTIMIZATION OF TOPICAL/PHOTOTHERAPY IN PSORIASIS
With the advance of pharmacological development for psoriasis, more and more targeted therapies such as monoclonal

antibodies or small molecule drugs have greatly improved the clinical outcomes of psoriasis treatments. However, availability
of these targeted therapies can be limited due to financial reasons or the policy of health insurance. Thus, topical medication
and phototherapies still remain the essential therapeutic options for most psoriasis patients. Actually, a large portion of
psoriasis patients can be benefited from topical medication and phototherapies only. These treatment modalities are really the
expertise of dermatologists and in this session, we will talk about some treatment concepts and principles which can optimize
the treatment outcomes of topical medication and phototherapies for psoriasis.
WU Nan-Lin
Sunday, May 04, 2025 - from 11:30 to 12:30 101A LEVEL 1 (MANDARIN)
Session:
Recent Advances in Photodermatology
RECENT ADVANCES IN UNDERSTANDING THE UV-INDUCED SKIN PHOTODAMAGE
As the first line organ exposed to sun light, skin is susceptible to solar UV-induced acute and chronic damage. Accumulation
of UV-induced photodamage may lead to undesirable and irreversible outcomes such as photoaging or skin carcinogenesis.
Over the past years, although a lot of studies have revealed mechanisms of UV-induced skin damage and established basic
concepts about photoprotection for skin, many UV-induced skin responses and underlying molecular mechanism still remain
unknown. Recently, some interesting investigations have disclosed novel molecular and cellular changes of skin in response
to UV irradiation. These novel findings have updated our current understanding of UV photo-response and provide new
insights into UV-mediated skin immunity and carcinogenesis.
WU Cheng-Lin
Saturday, May 03, 2025 - from 10:30 to 11:30 SOUTH LOUNGE (MANDARIN)
LEVEL 3
Session:
What's New and Challenging Cases in Dermatopathology
PREFERENTIALLY EXPRESSED ANTIGEN IN MELANOMA (PRAME): CHALLENGES AND FUTURE
PERSPECTIVES
Preferentially Expressed Antigen in Melanoma (PRAME), a cancer/testis antigen, plays a significant role in melanoma
pathogenesis and represents a focus in skin cancer research. As a nuclear receptor and transcriptional regulator, PRAME
inhibits retinoic acid signaling—a pathway crucial for cell differentiation and proliferation—thereby contributing to
tumorigenesis, epithelial-to-mesenchymal transition, and immune evasion.
The diagnostic utility stems from the differential expression pattern: PRAME is typically highly expressed in melanoma while
showing weak or absent expression in benign nevi. This distinction enhances diagnostic accuracy in differentiating malignant
melanoma from benign melanocytic lesions. Additionally, PRAME expression correlates with more aggressive melanoma
features, positioning it as a valuable prognostic marker.
The diagnostic applications of PRAME extend to various melanoma subtypes, including uveal melanoma (where expression
correlates with metastasis risk), acral melanomas (improving diagnostic accuracy in histopathologically ambiguous cases),
and potentially in differentiating melanoma from histologically similar entities like clear cell sarcoma or detecting lymph node
metastasis.
Beyond diagnostics, PRAME represents a promising therapeutic target. Its cancer-specific expression pattern makes it an
attractive candidate for immunotherapeutic approaches. Current research explores PRAME-targeted cancer vaccines and
adoptive T-cell therapies. However, challenges such as tumor heterogeneity and immune suppression mechanisms must be
addressed to optimize these therapeutic strategies.
Ongoing research into PRAME's molecular mechanisms continues to advance diagnostic and therapeutic applications,
offering hope for improved management of melanoma—a cancer that, despite recent treatment advances, still requires more
effective approaches to enhance patient outcomes.
YANG Shuxia
Saturday, May 03, 2025 - from 10:30 to 12:30 NORTH LOUNGE (ACDS) LEVEL
3
Session:
How Would You Reconstruct? The Repair Techniques of Skin Defects Including Tumor Surgery or
Cosmetic Purpose
CONSIDERATIONS ON THE MANAGEMENT OF LONGITUDINAL MELANONYCHIA IN CHILDREN
The optimal management of longitudinal melanonychia (LM) in pediatric populations remains clinically challenging. Given the
rarity of nail unit melanoma in children and their unique age-related characteristics, a "wait-and-see policy" has been widely
adopted. This study retrospectively analyzed 74 pediatric cases (≤18-year-olds) with excised LM in our department from

June 2016 to June 2022. Histopathological review by two senior dermatopathologists confirmed melanoma in 4 cases (5.4%)
with onset ages of 1, 3, 9, and 10 years (diagnosis confirmed at ages 8-13 years), all located on fingers. In comparison,
among 488 adult LM cases, 75 melanomas were diagnosed, including 4 cases with disease onset ≤18 years (initial
presentation ages: 5, 11, 16, and 18 years; diagnosis confirmed at 25-36 years), all exclusively involving fingernails.
Conclusion: Pediatric nail melanoma, though rare, exhibits early-onset potential. Progressive LM during adolescence warrants
heightened vigilance. Biopsy should be considered for lesions showing progression, particularly during peripubertal stages.
YONG Su-Boon
Saturday, May 03, 2025 - from 13:30 to 15:30 201ABC LEVEL 2
Session:
Pediatric Dermatology
TREATMENT OF PEDIATRIC ATOPIC DERMATITIS FROM A PEDIATRIC IMMUNOLOGIST'S POINT OF VIEW
The skin is a complex and extensive organ that harbors both innate and adaptive immune effector cells. These immune cells
serve as a crucial first line of defense against pathogens; however, genetic predisposition and environmental influences can
disrupt immune signaling, potentially resulting in hypersensitivity reactions. Among children, the most prevalent allergic skin
disorders include atopic dermatitis, urticaria/angioedema, and contact dermatitis. Atopic dermatitis (AD) and food allergy (FA)
are prevalent chronic conditions that significantly affect quality of life and contribute to a substantial socioeconomic burden.
AD is closely linked to the development of immunoglobulin E (IgE)-mediated FA. The underlying immune response involves
allergen-specific T helper type 2 (Th2) cells, which promote the release of pro-inflammatory cytokines, such as interleukin
(IL)-4 and IL-13. This cytokine activity drives B cell immunoglobulin class switching, leading to the production of specific IgE
(sIgE). In this lecture, I will share concise overview of pediatric atopic dermatitis, emphasizing recent advancements in their
diagnosis and management.
YU Peter Yu
Saturday, May 03, 2025 - from 13:30 to 15:30 201ABC LEVEL 2
Session:
Pediatric Dermatology
WHAT'S NEW IN PEDIATRIC DERMATOLOGY
This presentation will provide a comprehensive overview of the most recent advancements in pediatric dermatology as
presented at the 2025 World Congress of Pediatric Dermatology (WCPD). Key topics of discussion will encompass a range of
emerging and high-impact areas within the field, including but not limited to the latest diagnostic and therapeutic approaches
in atopic dermatitis, novel treatment strategies and biologic therapies for pediatric psoriasis, recent insights into the
classification and management of vascular lesions, and evolving understanding of genodermatoses with implications for
genetic counseling and targeted therapies.
YU Peter Yu
Sunday, May 04, 2025 - from 10:30 to 12:30 201ABC LEVEL 2
Session:
Atopic Dermatitis
USE OF ADVANCED SYSTEMIC TREATMENTS FOR PEDIATRIC AD? CURRENT EVIDENCE
Moderate-to-severe atopic dermatitis (AD) affects approximately 20-30% of pediatric patients, often resulting in significant
pruritus, sleep disruption, and impaired quality of life. While topical therapies remain the first-line treatment, a growing subset
of children requires systemic interventions for adequate disease control. Recent advances in immunopathogenesis have led
to the development and regulatory approval of targeted systemic therapies, including biologics and Janus kinase (JAK)
inhibitors, which have transformed the treatment landscape. This presentation will provide an evidence-based summary of the
current efficacy and safety data for biologic agents—namely dupilumab, lebrikizumab, and tralokinumab—and oral JAK
inhibitors including abrocitinib, upadacitinib, and baricitinib in the pediatric population. Dupilumab, an IL-4 receptor a
antagonist, is currently approved for children as young as 6 months and demonstrates robust, sustained efficacy with a
favorable safety profile and no need for laboratory monitoring. Lebrikizumab and tralokinumab, both IL-13 antagonists, show
promising efficacy in adolescents, though response onset may be slower compared to dupilumab. JAK inhibitors offer rapid
symptom relief, with upadacitinib and abrocitinib achieving the highest short-term EASI-75 rates (often >70-80%) and
demonstrating marked pruritus reduction within 1-2 weeks of initiation. Baricitinib, which has been approved for pediatric use
in some regions, also shows meaningful improvement, particularly in children aged 2-11 years, although its efficacy appears
more modest relative to JAK1-selective agents. While JAK inhibitors are generally well tolerated in the short term, they require
ongoing laboratory surveillance due to class-wide warnings regarding infections, thrombosis, and laboratory abnormalities.
Across trials, adverse events such as conjunctivitis (with biologics) and mild acne or gastrointestinal upset (with JAK
inhibitors) were generally manageable and infrequently led to treatment discontinuation. Ethnicity-based subgroup analyses

suggest consistent efficacy across Asian and Western pediatric populations. The selection of an optimal systemic therapy
must balance efficacy, onset of action, safety, administration route (subcutaneous vs. oral), age-specific approvals, and
access considerations. Shared decision-making with caregivers is essential, particularly when discussing potential long-term
safety data and real-world evidence that continue to emerge. In conclusion, biologics and JAK inhibitors represent a
significant advancement in pediatric AD management, offering rapid, targeted, and sustained disease control with the
potential to significantly enhance quality of life for affected children and their families.
YU Wei-Tai
Sunday, May 04, 2025 - from 10:30 to 11:30 101A LEVEL 1 (MANDARIN)
Session:
Updates in Molecular Diagnosis and Non-invasive Skin Diagnostic Tools
NONINVASIVE MEASUREMENT OF CUTANEOUS MICROCIRCULATION IN SKIN AND SYSTEMIC DISEASES
Recent advances in noninvasive modalities for assessing cutaneous microcirculation, including nailfold capillaroscopy, laser
Doppler flowmetry (LDF), optical coherence tomography, hyperspectral imaging, and thermography, have broadened clinical
applications in both dermatologic and systemic disorders. These techniques are employed in a wide range of conditions, from
skin diseases (e.g., psoriasis, eczema, vitiligo) to systemic disorders (e.g., diabetes, systemic sclerosis, lupus), enabling early
detection of microvascular dysfunction, monitoring of disease progression, and prediction of therapeutic responses. Our
findings demonstrate that LDF combined with cold stress testing reveals subclinical microangiopathy in systemic sclerosis,
while pretreatment LDF patterns predict response to visible light therapy in vitiligo. Such microcirculatory biomarkers hold
promises for enhancing early diagnosis and guiding personalized treatment strategies, ultimately and significantly improving
overall clinical outcomes.

ABSTRACTS
INDUSTRY SPONSORED
SYMPOSIA
BLAUVELT Andrew
Sunday, May 04, 2025 - from 12:30 to 13:30 101A LEVEL 1 (MANDARIN)
Session:
Luncheon Symposium by Lilly
HIGH BINDING AFFINITY AND LOW DISSOCIATION RATE: HOW EBGLYSS (LEBRIKIZUMAB) IS CHANGING
TREATMENT OF ATOPIC DERMATITIS
Lebrikizumab, an IL-13 targeting monoclonal antibody, has demonstrated robust efficacy in treating moderate-to-severe atopic
dermatitis (AD). In the ADvocate1 and ADvocate2 trials, significant improvements in EASI were observed at 16 weeks, with
many patients achieving EASI75 and EASI90 responses. Responses were maintained over 52 weeks with every 4-week
dosing. The potential for disease modification is also suggested by withdrawal data, as improvements were maintained in
about 50% of patients 36 weeks following drug discontinuation. The ADjoin study confirmed long-term efficacy, with sustained
skin clearance for up to 3 years and minimal use of rescue therapies. Conjunctivitis rates with both short-term and long-term
are less than 10%. In the ADapt trial, lebrikizumab provided clinically meaningful improvements in skin disease, itch, sleep
interference, and skin pain in patients previously treated with dupilumab. Lebrikizumab's high binding affinity and low
dissociation rate likely contribute to its effectiveness. In conclusion, lebrikizumab offers a promising new treatment option with
sustained efficacy, minimal need for additional therapies, and an acceptable safety profile for patients with moderate-severe
AD.
CHANG Hua-Ching
Sunday, May 04, 2025 - from 11:30 to 12:30 JOY LOUNGE LEVEL 4
Session:
Workshop by L'Oréal
PART II - ADJUVANT MANAGEMENT FOR ACNE BASED ON A SINGLE-ARM STUDY WITH SKINCARE
PRODUCTS IN TAIWAN
In Part II, the speaker will describe the results for the efficacy and safety of skincare products as an adjuvant for the medical
management of acne based on a single-arm study in Taiwan.
CHANG Hua-Ching
Sunday, May 04, 2025 - from 11:30 to 12:30 JOY LOUNGE LEVEL 4
Session:
Workshop by L'Oréal
PART I - REVIEW AND PROSPECTS OF DERMOCOSMETIC RECOMMENDATIONS IN ACNE MANAGEMENT
The speech will be divided into two parts. In Part I, the speaker will review the dermocosmetic recommendations from the
international guidelines for acne.
CHANG I-Jing
Sunday, May 04, 2025 - from 10:30 to 12:30 201EF LEVEL 2
Session:
Workshop by Galderma
AN INTEGRATIVE APPROACH TO ACNE MANAGEMENT
Acne and acme scars are among the top concerns of our patients at dermatology clinic, and it affects a wide range of
individuals at different ages.
In this session we would like to update the clinic science and experience on how to manage acne and prevent acne acar
scars in a integrative approach.
CHANG Eugene Yin-Shuo
Sunday, May 04, 2025 - from 15:30 to 16:00 JOY LOUNGE LEVEL 4
Session:
Workshop by Herbest
AI-POWERED SKIN ANALYSIS: THE NEXT GENERATION OF PRECISION DERMATOLOGY
The integration of AI into medical applications has revolutionized numerous fields. AI's ability to process vast amounts of data
and identify patterns with remarkable accuracy has opened new avenues for early detection and precise diagnosis of skin
conditions. Unlike traditional methods that sometimes struggle with ambiguous or early-stage dermatological issues, EVE V
utilizes advanced imaging techniques and machine learning algorithms to provide highly accurate diagnostics.
CHEN Yi-Hsien
Sunday, May 04, 2025 - from 10:30 to 12:30 201EF LEVEL 2
Session:
Workshop by Galderma
THE ROLE OF ONE ACNE IN ACNE SKINCARE MANAGEMENT
Acne is a prevalent inflammatory skin condition impacting adolescents and young adults globally. In addition to acute inflamed
skin lesions, acne can result in persistent sequelae, such as atrophic scarring and acne-induced hyperpigmentation,
significantly affecting patient self-esteem and quality of life. Recent evidence highlights epidermal barrier dysfunction as a
critical component in acne pathogenesis, with inflammation, hyperkeratinization, and increased sebum production playing
pivotal roles. By addressing unmet patient needs with innovative treatments and preventive strategies, "One Acne"
multifaceted approach supports patients through various treatment pathways, promoting patient adherence and improving
overall skin quality.
CHEN Jeng-Feng
Sunday, May 04, 2025 - from 12:30 to 13:30 201EF LEVEL 2
Session:
Luncheon Symposium by Galderma
PERSONALIZED SCULPTRA TREATMENT: TAILORED PROTOCOLS FOR GLOW AND VOLUME
RESTORATION
Poly-L-lactic acid (PLLA)-based injectables like Sculptra have revolutionized facial rejuvenation by stimulating collagen
production for long-lasting, natural results. However, optimizing outcomes requires a strategic approach tailored to individual
patient needs. This presentation introduces two distinct protocols designed to maximize the benefits of Sculptra: "Youthful
Glow", which enhances skin quality and firmness in the middle and lower face, and "Renewed Volume", which restores
structural support in areas prone to volume loss, including the temples and medial/lateral cheeks.
Through clinical case studies and expert techniques, I will demonstrate how each protocol can be effectively applied to
address aging-related changes while maintaining facial harmony. Attendees will gain insights into patient selection, injection
techniques, and treatment planning to achieve natural, rejuvenated results. By refining Sculptra's application through targeted
protocols, we can offer patients a customized approach to long-term facial revitalization.
CHEN Chien Ming
Sunday, May 04, 2025 - from 15:30 to 16:00 201EF LEVEL 2
Session:
Workshop by TBMS
LONG-TERM FOLLOW-UP WITH OPTICAL COHERENCE TOMOGRAPHY (OCT) EVIDENCE-BASED CLINICAL
RESULTS REVEAL THE PREVALENT PDRN PRODUCT, "REJURAN" BOOSTERS, BRIGHTEN SKIN TONE
REDUCING FACIAL FLUSHING
The excellence of Potenza lies not only in its therapeutic versitile tips, among them, the pumping tip, which is the best option
among many transdermal drug delivery route options. It not only creates cutaneous channel for drug infiltration, but also has
the thermal radiofrequrncy collagen stimulation effect.
Rejuran, a special skin booster, is currently formulated with C-PDRN and compounds such as tranecamic acid and vitamin C
and amino acids. With the combined action of potenza, it is possible to observe the regeneration and thickening of the
epidermis, the reduction of melanin activity, the decrease in blood vessels, and mild collagen production under OCT.
CHENG Carl Kuo-Liang
Sunday, May 04, 2025 - from 10:30 to 11:30 JOY LOUNGE LEVEL 4
Session:
Workshop by REEPOT
PIGMENTATION LASER REMOVAL REDEFINED: SIMULTANEOUSLY ACHIEVING DISRUPTION OF
PIGMENTATION AND REJUVENATION WITH LASER SHOCK WAVE ENERGY.
Unlike conventional selective photothermolysis, treating pigmentation with high energy of laser in cooling environment is
unique. Here we present removal of different pigmentary indication and rejuvenation with Reepot.
CHENG Carl Kuo-Liang
Sunday, May 04, 2025 - from 12:30 to 13:30 JOY LOUNGE LEVEL 4
Session:
Luncheon Symposium By BTL
FACIAL LIFTING REDEFINED: TIPS FOR SIMULTANEOUS LIFTING STRUCTURES AND BALANCING
EXPRESSIONS WITH EMFACE
Emface aims to increase our resting muscles tones of facial levator muscles, furthermore facial lifting and restoring attractive
expression may obtain when Emface, Exion and toxin were combined.
CHENG Carl Kuo-Liang
Sunday, May 04, 2025 - from 12:30 to 13:30 SOUTH LOUNGE LEVEL 3
Session:
Workshop by TBMS
NEW CONCEPT OF VASCULAR RESURFACING IN TREATING DIFFERENT VASCULAR INDICATION WITH
DERMA V
With advantage of ideal cryogen cooling and sequential pulse technology, the challenging small to large vessels could be
easily removed with multilayer approach technique which was proposed as Vascular resurfacing.
CHO Yung-Tsu
Sunday, May 04, 2025 - from 15:30 to 16:00 101A LEVEL 1 (MANDARIN)
Session:
Workshop by L'Oreal
DRY SKIN: WHY DOES IT MATTER AND HOW COULD IT BE MANAGED?
Dry skin, also known as xerosis, is a common skin condition that affects individuals of all ages, with its prevalence increasing
as people age. Dry skin is associated with an impaired skin barrier function, which may lead to skin inflammation and other
troublesome symptoms. In this talk, I will discuss the work-up for patients with dry skin, its impacts, the underlying
pathophysiology, and management strategies. Through this presentation, I hope to provide optimal advice for patients with dry
skin and ensure effective control of xerosis.
HUANG Chang-Ming
Sunday, May 04, 2025 - from 10:30 to 12:30 201EF LEVEL 2
Session:
Workshop by Galderma
WHAT YOU NEED TO KNOW ABOUT TOPICAL IVERMECTIN FOR ROSACEA AND OTHER SKIN
CONDITIONS
Topical ivermectin is a widely used treatment for rosacea, demodicosis, perioral dermatitis, and other skin conditions, offering
both antimicrobial and anti-inflammatory effects. Demodex mites, which reside in human hair follicles, can sometimes
overpopulate, leading to inflammation and various dermatological conditions. Recognizing the presence of Demodex and
understanding its role in disease is essential for accurate diagnosis and effective treatment. In this talk, I will review the
mechanism of action of topical ivermectin, its clinical effectiveness, and key supporting studies. Additionally, I will discuss
potential side effects and share practical insights from my clinical experience to optimize treatment outcomes.
HUANG Chen-Hao
Sunday, May 04, 2025 - from 10:30 to 12:30 201EF LEVEL 2
Session:
Workshop by Galderma
TOPICAL RETINOID'S ROLE IN SKIN QUALITY IMPROVEMENT
Topical retinoids have demonstrated remarkable efficacy in the clinical management of acne vulgaris. Furthermore, their
potential in combating skin aging is well-established. Many acne patients tend to discontinue topical retinoid treatment after
improvements, leading to the recurrence of the disease. This study aims to expand the application of topical retinoid in
enhancing skin quality, thereby providing a compelling rationale for patients to maintain applications of drugs and reap its
broader benefits.
HUANG Ching-Fu
Sunday, May 04, 2025 - from 10:30 to 12:30 NORTH LOUNGE LEVEL 3
Session:
Workshop by MERZ
MASTERING THE ART OF RADIESSE: CLINICAL APPROACHES FROM SKIN QUALITY TO STRUCTURE
Radiesse, a widely used dermal filler composed of calcium hydroxylapatite microspheres, has gained prominence in aesthetic
medicine for its ability to enhance both skin quality and underlying facial structure. We explore the clinical applications of
Radiesse, from improving skin texture and elasticity to restoring volume and definition to facial contours. Emphasizing a
holistic, patient-centered approach, this work outlines how Radiesse can be seamlessly integrated into facial rejuvenation
protocols to address a variety of aesthetic concerns,contributing to more natural-looking, long-lasting outcomes.
JUNG Jae-Yun
Sunday, May 04, 2025 - from 11:00 to 11:30 SOUTH LOUNGE LEVEL 3
Session:
Workshop by BP EC Limited
MULTIMODAL TECHNOLOGIES FOR MULTILAYER SKIN TIGHTENING: INNOVATIONS AND CLINICAL
APPLICATIONS OF RADIOFREQUENCY AND ULTRASOUND THERAPIES
As aesthetic medicine continues to evolve, achieving natural and lasting lifting effects through non-invasive treatments has
become a clinical priority. This presentation focuses on the latest advancements in radiofrequency (RF) and ultrasound (US)
technologies, highlighting their mechanisms across different skin layers and their roles in targeted tissue remodeling.
Emphasis will be placed on the synergistic use of multiple energy modalities to achieve precise, multilayered tightening with
improved efficacy and reduced discomfort. Through clinical cases and practical experience, this talk will provide insight into
optimizing treatment outcomes and exploring future directions in RF and US-based facial rejuvenation.
KANG Eunyoung
Sunday, May 04, 2025 - from 09:30 to 10:00 NORTH LOUNGE LEVEL 3
Session:
Workshop by Primestar
EDELWEISS EXTRACT EXOSOME SKIN BENEFITS
The lecture will be discussed Exosomes extracted from Edelweiss Callus are named as Edelweiss Exo Pro. Characteristically,
they contain five peptides that promote anti-inflammation, antioxidation, and regeneration of the skin. Edelweiss decrease not
only inflammatory factors but also proinflammatory cytokines down.
Exosome with using various method treatment can enhance skin elasticity, reduce inflammaion, anti-aging process as well.
This will be solution of treatment to make healty skin in the future.
KAO Jungting
Sunday, May 04, 2025 - from 14:30 to 16:00 SOUTH LOUNGE LEVEL 3
Session:
Workshop by BRIDGECON
CLINICAL APPLICATION AND EFFICACY OF BIAXIS HPT DUAL-PULSE MODE IN PICOSECOND LASER
TREATMENT
1.Key points and trends in the current picosecond laser market
2.Considerations and expectations of patients choosing laser treatments.
3.Exchanging experiences of utilizing BiAxis Pico and HPT Modes
4.Clinical case studies
5.Clinical treatment experience reveals benefits and patient feedback of HPT mode
6.Conclusion
KIM Sang Yub
Sunday, May 04, 2025 - from 10:30 to 11:30 JOY LOUNGE LEVEL 4
Session:
Workshop by REEPOT
REEPOT®: A NEW TREATMENT OPTION FOR EPIDERMAL PIGMENTATION REJUVENATION WITH
VASCULATURE SALVAGE LASER SURGERY(VSLS)
What is Reepot®?
The concepts and theories introduced above have been concretized into a procedure named "Vasculature Salvage Laser
Surgery (VSLS)," with the first laser system developed based on this concept being the Reepot® laser. The Reepot® laser,
based on a Q-switched 532nm wavelength, is the world's first targeted laser capable of actively controlling hemoglobin
chromophores associated with side effects and reduced treatment efficacy. This control is achieved through an advanced
cooling system and lesion recognition algorithm. Additionally, the laser system has been significantly improved in terms of
user convenience and safety by incorporating a new handpiece design and AR glasses.
1. Why Use 532nm?
The absorption coefficient graph shows that the 532nm wavelength has high selectivity for both melanin and vascular targets.
Historically, Q-switched 532nm was less favored for epidermal pigmentation due to its tendency to damage blood vessels,
leading to a preference for lasers like the 755nm Alexandrite or 1064nm Nd, which have lower selectivity for blood vessels.
However, if cooling can exclude blood vessels, the 532nm wavelength, which has 2.5 to 3 times higher selectivity for melanin,
can remove epidermal pigment more effectively.
2. Why Reepot ®'s Cooling is Different
Conventional contact cooling lasers indirectly transmit cold to the laser-treated area, as direct cooling of the laser glass
causes frost to form inside the handpiece, obstructing the laser beam. This indirect cooling makes it difficult to maintain a low
temperature and causes the temperature to rise sharply when the laser is in contact with the skin. Reepot ®'s technology
cools the entire glass without frost formation (CPTLTM), maintaining a consistent temperature even in contact with the skin,
thus sufficiently cooling the lesion.
3. The Importance of Lesion Recognition Algorithms
Solar lentigines, once thought to be simple pigment disorders, are now known to result from keratinocyte malfunction. Solar
lentigines develop due to increased proliferation and decreased turnover of malfunctioning keratinocytes, leading to melanin
deposition and brown discoloration. The variation in the intensity of solar lentigo colors seen in clinical practice is likely due to
differences in melanin content. Therefore, treating solar lentigines requires complete removal of mutated keratinocytes to
reduce the possibility of recurrence, rather than merely decreasing melanin content. Reepot ®'s fixed 4mm beam with 50%
overlap ensures uniform laser coverage of the lesion, making it far more consistent than manual handpiece operation.
Conclusion
The newly launched Reepot ® laser is expected to minimize side effects while significantly reducing the number of treatment
sessions required for common epidermal pigmentation issues like solar lentigines. Additionally, it offers a new treatment
option for more challenging pigment disorders such as Becker's melanosis, PUL, and café-au-lait spots, which traditionally
required over 20 treatment sessions

LAI Chun-Yu
Sunday, May 04, 2025 - from 13:30 to 14:30 SOUTH LOUNGE LEVEL 3
Session:
Workshop by Fotona
CLINICAL EXPERIENCE SHARING OF STARWALKER
The treatment of pigmentary lesions has been a long-standing challenge in dermatology. Over the years, laser technology has
evolved from photothermal treatments to the precision of picosecond lasers, offering new hope for effective and safer
outcomes. As technology advances, the need for improved solutions has driven the development of more diverseed laser
systems.
StarWalker is a unique laser platform that combines the benefits of both nanosecond and picosecond laser technology. This
dual capability allows for greater versatility in treating pigmentary disorders, delivering high energy for pigment fragmentation
while minimizing thermal damage. This results in better clinical outcomes, improved patient comfort, and reduced risk of side
effects.
I will discuss treatment protocols, patient responses, and safety considerations, along with real-world case studies that
highlight the efficacy of this technology and provide insights from clinical practice that demonstrate StarWalker's impact in
pigment management.
LEE Chen-Hung
Sunday, May 04, 2025 - from 16:00 to 16:30 201EF LEVEL 2
Session:
Workshop by TBMS
ANIKINE EXOSOMES: ADVANCED RECOVERY AND REGENERATION WITH SPLIT FACE COMPARISON IN
ANY KIND OF ENERGY-BASED TREATMENTS
Anikine Exosomes, derived from porcine umbilical cords, enhance facial aesthetic recovery and regeneration. This
presentation highlights their ability to accelerate healing, reduce inflammation, and boost collagen and elastin formation,
especially in energy-based treatments like lasers. Clinical split-face comparisons reveal faster recovery, superior skin texture,
and improved customers satisfaction with Anikine Exosomes. Safe, low-immunogenic, and ethically sourced, Anikine
Exosomes show revolutionary potential in aesthetics.
LEE Jennifer Po Ning
Sunday, May 04, 2025 - from 13:30 to 14:30 SOUTH LOUNGE LEVEL 3
Session:
Workshop by Fotona
COMBINATION TREATMENTS WITH FOTONA: ENHANCING RESULTS AND INCREASING PROFIT MARGINS.
This presentation will explore the strategic use of Fotona's advanced laser systems—particularly the StarFormer® and SP
Dynamis® platforms—in combination treatments that address a wide range of aesthetic concerns.
We will demonstrate how integrating Fotona's different modalities can synergistically improve results in various indications.
Additionally, this session will highlight how combination therapies can significantly increase patient satisfaction, enhance
treatment value, and ultimately lead to improved profitability for aesthetic practices.
LIN Liangchen
Sunday, May 04, 2025 - from 11:30 to 12:30 JOY LOUNGE LEVEL 4
Session:
Workshop by L'Oréal
ADVANCING MANAGEMENT OF FACIAL AGING: INTEGRATING SKINCARE WITH INJECTABLES
Integrative dermatologic care represents a growing trend in aesthetic medicine, emphasizing the combination of in-office
procedures with targeted topical regimens to enhance clinical outcomes. In injectable treatments, this approach supports skin
regeneration, reduces downtime, and improves patient satisfaction.
Poly-L-lactic acid (PLLA) is a biostimulatory injectable that promotes collagen production gradually over time. When paired
with topical adjuvants, such as the newly launched SkinCeuticals Collagen III Amplifier, outcomes may be further optimized.
This innovative serum is formulated to stimulate collagen type III, a key component of youthful dermal architecture. Its
synergistic use with PLLA may enhance neocollagenesis and support better long-term results.
This presentation will explore a dermatologist-led protocol combining injectable PLLA with Collagen III Amplifier to illustrate
the concept of integrated skin care for injectables. It will also highlight the updated SkinCeuticals guidelines on topical
regimens supporting aesthetic procedures. The Collagen III Amplifier is positioned as a strategic post-injection solution that
complements the regenerative effects of PLLA, marking a forward-looking approach to comprehensive aesthetic treatment
planning.
LIN Liangchen
Sunday, May 04, 2025 - from 12:30 to 13:30 SOUTH LOUNGE LEVEL 3
Session:
Workshop by TBMS
PRECISION IN VASCULAR LASER THERAPY: CLINICAL APPLICATIONS OF DUAL-WAVELENGTH DERMAV
Facial vascular lesions remain a common yet challenging concern in dermatologic practice. The DermaV system provides a
dual-wavelength platform (532nm and 1064nm) that allows for versatile and controlled treatment of a range of vascular
presentations, from superficial telangiectasia to deeper reticular vessels.
The device's variable sequential pulse (VSP) technology enables tailored pulse modulation, allowing clinicians to adjust
treatment parameters according to vessel size and depth. In addition, real-time temperature sensing and IntelliTrak
motion-tracking features contribute to treatment consistency and patient safety by providing feedback-driven energy delivery.
DermaV operates without consumable dye kits and supports multiple indications, including vascular lesions, pigmentation
disorders, and skin rejuvenation, enhancing its practicality in clinical settings. With higher peak power and flexible settings, it
offers an efficient workflow for physicians managing diverse skin concerns.
This presentation will outline the clinical rationale and technical considerations for using DermaV in facial vascular treatment,
supported by practical experience and treatment planning strategies for optimizing safety, efficacy, and patient outcomes.
LIN Yu-Min
Sunday, May 04, 2025 - from 14:30 to 16:00 SOUTH LOUNGE LEVEL 3
Session:
Workshop by BRIDGECON
NOURKRIN® AND PRT: A NOVEL NON-INVASIVE STRATEGY FOR HAIR GROWTH RESTORATION
Hair follicle health is deeply influenced by its microenvironment, in which proteoglycans play a crucial structural and regulatory
role. Nourkrin® is the only product worldwide utilizing Proteoglycan Replacement Therapy (PRT), a patented
non-pharmaceutical approach designed to restore proteoglycan levels in the hair follicle and support the normal hair growth
cycle.
In this lecture, Dr. Te-Peng Tseng will explore the biological rationale behind PRT and its impact on hair follicle nutrition,
regeneration, and cycle stabilization.
Key topics to be covered include:
The role of proteoglycans in hair follicle physiology
Mechanisms of action behind PRT and Nourkrin®'s unique marine-derived formulation
Clinical trial outcomes demonstrating efficacy in androgenetic and diffuse hair loss
Practical observations from Asian patient populations and implications for integrative hair loss management
This session offers a new perspective on managing hair loss from a nutritional and molecular level, presenting PRT as a safe
and innovative approach in modern trichology.
LO Yu-Pei
Sunday, May 04, 2025 - from 14:30 to 16:00 SOUTH LOUNGE LEVEL 3
Session:
Workshop by BRIDGECON
BEYOND THE SURFACE: JETPEEL AS A DUAL SOLUTION FOR AGING SKIN AND POST-LASER HEALING
In modern aesthetic medicine, there is growing demand for treatments that not only address visible signs of aging but also
support skin recovery following invasive procedures. JETPEEL, a needle-free transdermal delivery system, offers a unique
dual-action approach—combining non-invasive deep infusion of active ingredients with lymphatic drainage and exfoliation—to
rejuvenate aging skin and accelerate post-laser healing.
This session will explore the scientific mechanism behind JETPEEL technology and its efficacy as both a standalone
anti-aging treatment and a complementary therapy for post-laser care. Clinical insights will demonstrate its ability to:
Improve skin hydration, elasticity, and texture through dermal stimulation
Reduce post-laser inflammation, erythema, and downtime
Deliver actives such as hyaluronic acid, peptides, and vitamins directly into the dermal layer without compromising the skin
barrier
Enhance patient comfort and satisfaction with a completely non-invasive protocol
Join us as we go ""beyond the surface"" to uncover how JETPEEL redefines skin rejuvenation and recovery with visible,
lasting results.
LOWE Stephen
Sunday, May 04, 2025 - from 13:30 to 14:30 201EF LEVEL 2
Session:
Workshop by BridgeCon
SCITON STAX - COMBINATION THERAPIES USING BBL HEROIC ARTIFICIAL INTELLIGENCE
As patient expectations in Asia evolve, practitioners must adapt with smarter, more effective laser treatment strategies. In this
dynamic session, discover how Sciton STAX—powered by BBL HEROic's intelligent technology—is reshaping the landscape
of aesthetic medicine through personalised, combination laser treatments. Learn how to achieve superior results with less
downtime, and understand how Broadband Light HERO with Intelligent Control is able to safely treat Asian skin types and
multiple patient aesthetic concerns.
LU Sophie Pei-Hsuan
Sunday, May 04, 2025 - from 10:30 to 12:30 NORTH LOUNGE LEVEL 3
Session:
Workshop by MERZ
THE USE OF INCOBOTULINUMTOXIN A FOR FACIAL AESTHETICS
With the uniqueness of Incobotulinumtoxin A, I will share my expertise using Incobotulinumtoxin A in different clinical scenario
to achieve holistic facial aesthetics.
MARINI Leonardo
Sunday, May 04, 2025 - from 13:30 to 14:30 SOUTH LOUNGE LEVEL 3
Session:
Workshop by Fotona
EVOLVING STANDARDS IN LASER TECHNOLOGY: WHERE STARWALKER LEADS THE WAY
Evolving Standards in Laser Technology: Where Starwalker leads the way
Leonardo Marini, SDC The Skin Doctors' Center Trieste (I) Susanna Marini, MB BCh BAO (UK) SDC The Skin Doctors'
Center Trieste (I)
Leonardo.marini@skindoctors.it
Susanna.marini@skindoctors.itLaser
Technology represents an important "ingredient"of many simple and advanced treatments in modern medicine and surgery.
Unstoppable laser evolutioncontinuesto surprise even the most experienced laser experts. Picosecond QS lasers have
contributed significantly to the success of this incredible progressionduring the last decade. More laser beam delivery options,
more power, more treatment versatility, more laser emission stability, more effective laser-operator interfaces, more
technological miniaturization have changed enormously the way we use this highly sophisticated family of laser
systems.Among the various proposals available on the market, the Fotona Starwalker trio stands outforitsunsurpassed
concentrationof allthe most advanced picosecond QS laser characteristics.Advanced tattoo removal has been never so
effective and reproducible, epidermal and dermal endogenous pigments have never been so easilyeliminated, hypertrophic
scar remodelling has been never so gentle, skin rejuvenation procedures have been never so well tolerated,
trans-epidermaldrug delivery has been never so simple. The advent of LIOB -laser induced optical breakdown -technology is
opening incredible new therapeutic scenarios, but higher PS energies are needed to allow better modulations of clinical
results. The impressive performance of the new Starwalker PicoPro allows the unlash of previously unthinkable PS laser
energies providing an impressive versatility in laser-tissue effects even when LIOB is used. When dealing with such huge
laser energies, laser light transmission and final delivery on biological tissues need to be extremely well controlled to provide
smooth and effective performance. The Fotona Starwalker Family features unique solutions to optimize PS laser delivery
thanks to the implementation of state-of-the-art laser transmission through incredibly performing articulated arms and
jewel-like ultra-precise titanium handpieces.Fractional PS laser-tissue interaction is gaining higher and higher popularity
among laser operators thanks to its unique biological effects. To better distribute PS laser pixels on biological tissues, different
size and shape of footprints are quite important and Fotona Starwalkers can now count on three versatile shapes to fulfil most
of treatment requirements.
Leading the way in laser technology is not easy but Fotona has been able to be at the forefront of laser innovation since its
foundation 61 years ago. The Fotona PS Starwalker family represents one of the zeniths of Fotona research and proudly
contributes to the achievement of highly effective and reproducible clinical results in dermatological treatments.
OH Seung Min
Sunday, May 04, 2025 - from 13:30 to 14:00 JOY LOUNGE LEVEL 4
Session:
Workshop by Oligio X
UNDERSTANDING AND SELECTING MONOPOLAR RF DEVICES BASED ON ELECTROMAGNETICS AND
TISSUE THERMAL RESPONSE ANALYSIS
Monopolar RF is one of the most renowned and widely used treatment modalities for improving skin elasticity and reducing
fine wrinkles. Traditionally, frequencies in the 1-2 MHz range have been used to target deeper tissue layers, while 6.78 MHz
has primarily focused on superficial treatments. However, with the integration of advanced knowledge from the field of
electromagnetics and a deeper understanding of tissue thermal response, 6.78 MHz devices are no longer limited to
superficial skin tightening. An increasing number of studies suggest that this frequency can effectively deliver heat to deeper
layers, thereby influencing broader areas of tissue.
By combining findings from cellular and tissue-level research with empirical clinical observations, we aim to offer a deeper
understanding of monopolar RF procedures. In particular, we seek to provide an evidence-based explanation of how the
newly upgraded OLIGIO X from WONTECH achieves more powerful and effective results through its advanced features.
OKU Kentaro
Sunday, May 04, 2025 - from 14:00 to 14:30 JOY LOUNGE LEVEL 4
Session:
Workshop by Density
EVALUATION OF THE EFFICACY OF A NOVEL SEQUENTIAL MONOPOLAR AND BIPOLAR PULSED RF FOR
FACIAL CONTOURING AND SKIN TIGHTENING
To enhance the therapeutic effects of facial rejuvenation, it is essential to induce both horizontal changes, such as skin
tightening, and vertical changes, known as facial contouring. A novel technology called Sequential Monopolar and Bipolar
Pulsed Radiofrequency (SMBPRF), branded as DENSITY, has the potential to achieve both effects simultaneously.
In this session, we will explore the analysis of vertical and horizontal changes, accompanied by clinical results using a specific
treatment method developed by the speaker.
RASSAMEECHOTE Richard
Sunday, May 04, 2025 - from 10:30 to 12:30 201EF LEVEL 2
Session:
Workshop by Galderma
FRESH GLOW WITH SKINBOOSTERS: ENHANCING SKIN QUALITY THROUGH SCIENCE AND ART
In this presentation, we explore the transformative potential of Restylane® Skinboosters in achieving radiant, hydrated, and
youthful skin. By integrating clinical expertise with the innovative Galderma Facial Assessment Scale (FAS), practitioners can
tailor treatment plans that address individual patient needs with precision. The session will highlight the six clinically proven
benefits of skinboosters—ranging from enhanced hydration and elasticity to smoother texture and increased luminosity—while
providing practical protocols and facial mapping strategies to optimize results. Attendees will gain actionable insights into
using skinboosters not only as a rejuvenation tool but also as a foundation for long-term skin health.
RASSAMEECHOTE Richard
Sunday, May 04, 2025 - from 12:30 to 13:30 201EF LEVEL 2
Session:
Luncheon Symposium by Galderma
THE AART OF SCULPTRA: A CLINICAL APPROACH TO SAGGING WITH "FILLING LIFT" AND "SLIMMING
LIFT" PROTOCOLS
Facial sagging remains one of the most challenging aesthetic concerns, especially as it relates to structural volume loss and
soft tissue descent. This presentation introduces "The AART of Sculptra"—a refined clinical methodology that blends artistry
and anatomy to deliver natural, long-lasting rejuvenation. The talk will focus on two innovative treatment protocols: the Filling
Lift, designed to restore deep volume and support, and the Slimming Lift, aimed at enhancing facial contour and defining the
lower face. Attendees will gain insights into patient assessment, injection planning, and procedural techniques, supported by
clinical case studies that demonstrate outcomes using Sculptra's biostimulatory properties.
SOCHAROENTAM Kamphon
Sunday, May 04, 2025 - from 12:30 to 13:30 ELEGANCE LOUNGE LEVEL 4
Session:
Luncheon Symposium by UltraClear
REAL-WORLD EXPERIENCE WITH ULTRACLEAR® LASER IN ASIAN SKIN: BALANCING EFFICACY AND
SAFETY IN SKIN REJUVENATION
Background:
Asian skin, typically classified as Fitzpatrick skin types III to V, poses unique challenges in energy-based treatments due to
increased melanocyte activity and a higher risk of post-inflammatory hyperpigmentation (PIH). UltraClear®, a novel 2910 nm
cold-fiber fractional laser, offers a promising solution for skin rejuvenation with minimal thermal damage.
Objective:
To share real-world clinical experience using UltraClear® laser in Asian patients, focusing on treatment outcomes, safety
profile, and patient satisfaction.
Methods:
A retrospective case series was conducted in aesthetic dermatology clinics involving Asian patients undergoing UltraClear®
treatments for indications including photoaging, acne scarring, skin texture irregularities, and pore refinement. Parameters
were adjusted according to skin type and clinical goals. Post-treatment care protocols were standardized to mitigate potential
complications.
Results:
Across asian patients, the majority demonstrated significant clinical improvement in skin clarity, texture, and radiance within 1
to 3 sessions. Downtime was minimal (1-3 days of erythema and desquamation), and no major adverse events were reported.
The incidence of PIH was extremely low when appropriate energy settings and post-care protocols were followed.
Conclusion:
UltraClear® laser provides an effective and safe option for skin rejuvenation in Asian populations when personalized protocols
are applied. Its unique cold-fiber fractional technology minimizes thermal damage, making it suitable for melanin-rich skin
types. Further studies with larger cohorts and long-term follow-up are warranted to reinforce these findings.
TSENG Jonathan Te-Peng
Sunday, May 04, 2025 - from 14:30 to 16:00 SOUTH LOUNGE LEVEL 3
Session:
Workshop by BRIDGECON
SPECIFIC PROTEOGLYCANS IN HAIR GROWTH AND HAIR LOSS
Proteoglycans have massive molecular diversity and are complex components that regulate several processes in the body.
They can be considered the third biological language after DNA and proteins. Clinical evidence shows that follicular
proteoglycans' deregulated synthesis and function play central roles in the development and progression of MPHL (AGA),
FPHL, and TE. Proteoglycan replacement therapy can also be judged as well—tolerated and safe to use in males and
females with diffuse hair loss.
WANG Hsiao-Han Christine
Sunday, May 04, 2025 - from 14:30 to 15:30 JOY LOUNGE LEVEL 4
Session:
Workshop by Victory 8
BIOJUVE: REVOLUTIONIZING AESTHETIC MEDICINE WITH PROBIOTIC SKINCARE TECHNOLOGY
In the rapidly evolving field of aesthetic medicine, integrating cutting-edge technologies is essential for achieving optimal
patient outcomes. Biojuve represents a groundbreaking advancement in skincare, utilizing probiotic technology to
revolutionize how we approach skin health and rejuvenation. This presentation will explore how Biojuve's unique formulation
leverages the skin's natural microbiome to enhance barrier function, promote cellular regeneration, and combat the visible
signs of aging. Attendees will gain insights into the science behind probiotic skincare, including its mechanisms of action and
the clinical evidence supporting its efficacy. Additionally, we will discuss practical applications of Biojuve in aesthetic practice,
highlighting its role in complementing existing treatments and elevating patient satisfaction. Join us to discover how Biojuve is
setting a new standard in aesthetic medicine, offering a scientifically validated, non-invasive solution for achieving radiant,
youthful skin.
WIDGEROW Alan
Sunday, May 04, 2025 - from 12:30 to 13:30 201EF LEVEL 2
Session:
Luncheon Symposium by Galderma
POWER OF 3 - NOVEL, ADIPOCYTE MEDIATED REGENERATIVE MECHANISM OF ACTION UNIQUE TO
SCULPTRA
This study presents PLLA-SCATM regenerative gene upregulation based on 3 month biopsy analysis examining inflammatory
and regenerative responses to the product. Aside from controlled inflammation, this analysis also demonstrates that
PLLA-SCATM upregulated multiple adipogenic genes, which may suggest regenerative involvement of all three skin layers
(epidermis, dermis, and subcutaneous fat).

皮膚科王修含醫師

賀！王修含醫師榮任 AMWC Southeast Asia 國際學術顧問委員會委員

王修含醫師演講紀錄：AMWC Asia-TDAC 2025 臺灣皮膚科醫學會春季學術討論會